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ABSTRACT 
Özdemirhan Serçin: Interactions of Claspin with Replication and Checkpoint Proteins  
(Under the direction of Aziz Sancar, M.D., Ph.D.) 
  
 The DNA damage and replication checkpoint ensures genome stability by 
monitoring DNA replication and the integrity of the genetic material. In the presence of DNA 
damage or replication stress, the checkpoint is activated. The activation of checkpoint grants 
time for cells to repair the damage and to overcome replication stress. Activation of the 
checkpoint requires phosphorylation of several important targets, such as checkpoint effector 
transcription factor p53 and checkpoint transducer kinase Chk1. The mediator protein 
Claspin was shown to be important in ATR-dependent Chk1 phosphorylation. Here I 
describe the purification and characterization of checkpoint- and replication-related domains 
of human Claspin. I have identified a minimal functional domain of Claspin necessary and 
sufficient for activation of ATR dependent Chk1 phosphorylation in vitro. Claspin has also 
been shown to bind to DNA that mimics the structure of replication fork. I identified a 
minimal DNA binding domain in Claspin. It has also been suggested that Claspin interacts 
with replication fork proteins. To understand which replication fork proteins Claspin directly 
interacts with, I have purified the following replication fork factors: Rad17-RFC, polymerase 
epsilon, Timeless and Cdc45. I then mapped the regions of Claspin involved in  each protein-
protein interaction  using in vitro immunoprecipitation assays. My results suggest that 
Claspin interacts with the aforementioned replication fork proteins and replication fork DNA. 
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This work provides new insights into the replication and checkpoint functions of 
Claspin and reconstitution of a well-defined minimal in vitro checkpoint system. 
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All organisms are constantly under the threat of genotoxic insult which affects the 
stability and integrity of their genomes. External sources of DNA damage including the 
following: ultraviolet light (UV), high energy photons, ionizing radiation and reactive 
chemicals. Internal sources of DNA damage include byproducts of cellular metabolism, 
erroneous DNA replication, repair and recombination (1, 2). The stability and integrity of the 
genome is essential for survival and accurate transmission of the genetic material from parent 
cells to daughter cells. Failure to respond to these insults results in genomic instability, 
cancer and several other genetic diseases (3). Eukaryotic cells respond to such insults by 
controlling cell cycle progression and repairing the DNA damage. 
 Mammalian cells utilize multiple systems to inspect the integrity and stability of their 
genomes. Cell cycle checkpoints that control cell cycle progression are activated upon 
recognition of the DNA damage or incomplete replication. Upon recognition of the DNA 
damage, cells respond to the damage according to the type and extent of the damage (1, 4) 
(Figure 1.1). These responses include the following: a transcriptional response that activates 
genes to the stop cell cycle or to activate DNA repair-related genes; cell cycle arrest, which 
prevents the cell from committing to the next phase of the cell cycle and grants the cell 
additional time for DNA repair and apoptosis, or programmed cell death, which eliminates 
extensively damaged and genetically altered cells and preserve the integrity of the organism 
(3, 4). Several components of the DNA damage signaling pathway have been documented to 
function as oncogenes or tumor suppressors (3). Mutations or altered expression patterns of 
these genes have been implicated in tumorigenesis and are therefore potential drug targets for 
cancer treatment (5). 
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CELL CYCLE CONTROL 
 
 Eukaryotic cells have timed division cycles that are controlled and affected by 
external and internal stimuli. These cycles, in order, include the following: G1, S, G2 and M 
phases. Proliferating cells control and regulate their growth and inspect the conditions for 
each phase by complex mechanisms called checkpoints. All eukaryotic cells control cell 
cycle progression through regulation of proteins called cyclins. Multiple cyclins are 
expressed, utilized and degraded in a robust and fast process that regulates cyclin dependent 
kinases (CDKs) generating precise timing and synchronizing  cellular metabolism. 
 DNA replication is one of the many processes that are tightly regulated by cell cycle 
components. Loss of regulation in this metabolism has been implicated in cancerous 
transformation, inherited diseases and chromosomal aberrations. The precise timing of cell 
cycle progression is essential for organismal survival. After the decision to perform cell 
division is made, by considering growth conditions such as presence of growth factors, cells 
start to replicate their DNA.  
G1/S checkpoint 
The G1/S checkpoint serves to control the decision to initiate DNA replication, from 
DNA replication defined during the M and G1 phases of the cell cycle (3). Several CDKs and 
cyclins control this checkpoint in mammals, including Cyclin D and Cyclin E and Cdk4 and 
Cdk6 (6). The tumor suppressor protein p16 keeps Cyclin D/E and Cdk4/6 in an inactive 
form until the cell decides to divide (6). One other element of this system is the oncogene 
Cdc25 (Cell division cycle 25 A). Cdc25 is a phosphatase that removes inhibitory phosphates 
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on CDKs enabling cell cycle progression is notably inactivated upon DNA damage to 
prevent entry into S phase (1, 5). Upon inhibition of p16 and the presence of active oncogene 
Cdc25, Cdk4/6-Cyclin D complexes are formed and the tumor suppressor pRb 
(Retinoblastoma) is repressed; as a result of pRb repression, E2F is expressed (E2 
Transcription factor), which enables the expression of many genes that encode proteins 
required for DNA replication.  Once activated, these genes lead to entry into S phase by 
expression of CyclinE (7, 8). Active Cdk2/6 enables activation of multiple targets, including 
the replicative helicase, to start DNA replication (7). In S phase, DNA replication is 
monitored by the intra-S and replication phase checkpoint responses. 
DNA replication and intra-S checkpoint 
The DNA replication checkpoint ensures accurate transmission of the genetic material 
to daughter cells by monitoring whether DNA replication is completed and preventing 
premature entry into G2 phase when replication forks may have stalled due to DNA damage 
(1-4). The intra-S phase checkpoint ensures replication fork stability and the continuation and 
fidelity of replication forks by inhibiting late origin firing when DNA damage is present (3). 
The intra-S phase checkpoint also slows the movement of the replication fork in the presence 
of replication stress inducing agents (9). Although the replication and intra-S checkpoints 
have different downstream effectors, they utilize a similar mechanism with a common set of 
signaling proteins. Several classes of proteins involved in these systems have been identified 
and categorized, including the following: DNA damage sensors, mediators,  transducers, 
effectors (Figure 1.2) (3).  
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DNA damage sensors 
Initiation of the checkpoint cascade requires detection of the DNA damage, stalled 
replication fork or other replication stress (2- 4). We can classify the proteins in this class 
into two groups: sensor kinases and sensor proteins. Sensor kinases are a group of proteins 
that are activated by different types of DNA damage or replication stress and phosphorylate 
and activate effectors or transducers with the help of mediators and other sensor proteins (3). 
The members of this group are also members of the PIKK (phosphoinositide 3-kinase-like 
kinase) family of proteins, which are distantly related to lipid kinases and have a conserved 
atypical protein kinase domains and HEAT (Huntington, elongation factor 3, A subunit of 
phosphotase 2A and Tor1) repeats that have been implicated in recognition of DNA damage 
in distant eukaryotes (4, 10). 
 ATM (Ataxia telangiectasia mutated) is a 350 kDa protein kinase and has been 
discovered in individuals affected by the rare disorder called ataxia telangiectasia. Ataxia 
patients exhibit severe symptoms such as neurodegeneration, immune deficiency, 
predisposition to cancer and genome instability (11). The high incidence of cancer was later 
discovered to be related to an inability to respond to double strand breaks in DNA. Similarly 
to the other PIKKs, ATM phosphorylates SQ/TQ motifs in a wide variety of DNA damage, 
cell cycle and checkpoint proteins. Such targets include the checkpoint kinase Chk2, the 
transcription factor p53, BRCA1 (breast cancer type 1 susceptibility protein) and NBS1 
(Nijmegen Breakage Syndrome 1) (2, 12). Recent studies suggest that, like its yeast homolog 
Tel1, ATM primarily responds to double strand break damage in DNA caused by exposure to 
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ionizing radiation (IR) and collapsed replication forks (2-4). ATM also auto phosphorylates 
itself to form a monomer and an active kinase (12).   
 DNA-PK (DNA dependent protein kinase) is a heterotrimeric protein complex 
consisting of the Ku70/Ku80 dimer and the catalytic subunit DNA-PKcs (450 kDa). 
Ku70/Ku80 is a dimer that recognizes the double strand DNA breaks, and then recruits and 
activates DNA-PKcs to promote the non-homologous end joining mechanism of  double-
strand break repair (2, 3, 11, 13). Recent studies suggest that DNA-PK shares many targets 
with other PIKK members, including checkpoint kinases Chk1 and Chk2, RPA (Replication 
protein A), NBS1, p53 and ATM (3). Thus DNA-PK is an important member of the PIKK 
family due to its wide spectrum of targets (3). 
 ATR (ATM and Rad3 related) is a 300 kDa protein kinase and a member of the PIKK 
family that was discovered through its similarity to ATM and Rad3 and found to be mutated 
in Seckel syndrome patients (2-4). Seckel syndrome is an autosomal recessive disorder which 
shows some overlapping symptoms to ataxia telangiectasia patients. ATR, similar to DNA-
PKcs, functions with a partner protein ATRIP (ATR interacting protein). Recent research 
suggests that ATR primarily responds to bulky DNA lesions caused by reactive chemicals, 
UV and by RPA-covered single-stranded DNA that forms during replication stress due to 
uncoupling events between the replicative helicase and the polymerase (3, 14, 15). It has also 
been shown that ATR may phosphorylate and activate ATM, which suggests ATR can 
activate the ATM pathway (16). ATR, like other members of the PIKK family, was reported 
to phosphorylate a variety of checkpoint targets, including the checkpoint kinase Chk1, the 
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transcription factor p53, the checkpoint clamp Rad9 and the ssDNA-binding protein RPA in 
response to replication stress or UV- or reactive chemical-induced bulky DNA adducts (3).  
 Other DNA damage sensor proteins have been shown to enable or recruit DNA 
damage sensor PIKK to initiate the signaling cascade. Such proteins include the following: 
the checkpoint clamp Rad9-Rad1-Hus1 (9-1-1) complex, the ssDNA-binding protein RPA, 
the checkpoint clamp loader Rad17-RFC (Replication factor C), Mre11–Nbs1–Rad50 
(MRN), other DNA damage repair system proteins such as transcriptional repair protein 
CSB, excision repair protein XPA and base excision repair DNA glycosylases (3, 17-20). 
 The checkpoint clamp 9-1-1 and the checkpoint clamp loader Rad17-RFC  are 
checkpoint counterparts of the canonical clamp PCNA and clamp loader p140-RFC and have 
been implicated in loading at the DNA junctions formed during incomplete replication and at 
DNA repair intermediates (3). The phosphorylated Rad9 C-terminus has been shown to be 
required to initiate TopBP1-dependent ATR checkpoint activation (21, 22). Recent studies 
suggest that the Rad9 C-terminus acts as an activator of ATR (21). Rad17-RFC, is a highly 
conserved protein and the counterpart of p140-RFC complex, where Rad17 replaces p140 in 
the replicative clamp loader. Rad17-RFC has been shown to be required for loading 9-1-1 
onto primed DNA junctions in vitro (23). Studies in Xenopus also suggest that Rad17-RFC 
monitors DNA replication independent of its clamp loader function by enabling 9-1-1, 
TopBP1 and ATR interaction (24). Rad17 was shown to interact with the checkpoint 
mediator protein Claspin in human cells and Xenopus egg extracts. This interaction was 
further stabilized upon treatment with replication stress inducing agents or UV and suggested 
that this interaction might be mechanistically important for Claspin recruitment to stalled 
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replication forks (25, 26). Due to its importance in the ATR-Chk1 pathway, we have studied 
the  interaction of Rad17-RFC with Claspin in Chapter 3 (27). 
 RPA is the main ssDNA-binding protein in eukaryotes (3). RPA is required for DNA 
replication and excision repair and other DNA metabolic processes (3). This variety of 
functions of RPA makes it central for functions in the DNA replication checkpoint. Recent 
studies show that RPA binds to ATRIP, thus enabling the recruitment of ATR to the DNA 
damage site (28). During replication, when the replicative polymerase stalls at DNA damage 
sites and where the replicative helicases continue to unwind DNA, RPA covers the ssDNA. 
This long patch of ssDNA covered by RPA serves as a docking station for the initiation and 
recruitment of multiple checkpoint proteins, most importantly the ATR-ATRIP complex for 
initiation of the checkpoint cascade (15). (Figure 1.3)   
 DNA repair proteins involved in mismatch repair, transcriptional repair, base excision 
repair proteins and nucleotide excision repair have been found to interact with ATR (17-20). 
However, their mechanism of function to activate this PIKK member has not been fully 
understood. It has been suggested that their core activities may enable formation of a global 
checkpoint intermediate: RPA covered ssDNA, which may in turn activate ATR (15). 
Mediators 
Mediator proteins in the DNA damage signaling pathway enable sensor kinases to 
phosphorylate their targets by helping formation of the kinase-substrate complex through 
scaffolding (3). However, this class of proteins has been shown to play multiple  roles in 
addition to their scaffolding activities, which complicates the definition of this class of 
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proteins. Well-defined members of this class include Claspin, TopBP1, BRCA1, 
Timeless/Tipin, 53BP1 and MDC1 (3). 
 BRCA1 (breast cancer type 1 susceptibility protein) is a tumor suppressor protein 
containing a conserved BRCT (BRCA1 C terminus) motifs and was found mutated in Type 1 
breast cancer patients. BRCA1 has been shown to play important roles in recombinatorial 
repair and transcription response and phosphorylation of Chk2 through interactions of BRCT 
and FHA (Forkhead associated domain) domains found in multiple checkpoint proteins such 
as Chk2 (3). Recent research also suggests that it might have an effect on Chk1 
phosphorylation through an interaction with Claspin (29).  
 Timeless and Tipin (Timeless-interacting protein), which are conserved through 
eukaryotes and play important roles in replication and circadian clock regulation in insects, 
have been recently identified as checkpoint mediators due to their interactions with Claspin, 
RPA and ATRIP (30-33). Depletion of Tipin in Xenopus egg extracts results in loss of Chk1 
phosphorylation in response to replication stress-inducing agents (31). Research suggests that 
Claspin might be recruited to RPA-covered DNA through Tipin directly, through protein-
protein interactions (30). Timeless/Tipin homologs in S. pombe Swi1/Swi3 have also been 
shown to recruit the Claspin homolog Mrc1 to DNA and to replicating chromatin (33). The 
yeast homologs of the Timeless/Tipin complex and Claspin may also affect replication fork 
stability in yeast (33-36). Csm3, Tipin homolog in S. cerevisiae, deleted strains show slower 
replication rates, which may be consistent with replication stress (31).  
 TopBP1 (Topoisomerase binding protein 1) is another well-studied mediator of the 
ATR-dependent checkpoint (3). TopBP1 contains BRCT motifs, which are implicated in 
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DNA repair and checkpoint activities (1, 37). Studies in the Xenopus egg extract and human 
cells have shown that TopBP1 is a direct activator of ATR enabling Chk1 phosphorylation 
upon UV damage or replication stress (38). Recent research also suggests that TopBP1 can 
activate ATR in a minimal reconstituted in vitro checkpoint assay (37, 39). Knockdown of 
TopBP1 in human cells showed that TopBP1 acts upstream of Claspin for mediation of Chk1 
phosphorylation by ATR (40). It has been suggested that TopBP1 is recruited to the damage 
site or unreplicated DNA through interactions with RPA and phosphorylated Rad9 C-
terminus (28, 40). TopBP1 was also shown to have a strong binding preference for damaged 
DNA (37). However, this role and how it functions has not been well-studied. Other studies 
in Xenopus egg extracts and in vitro reconstitution assays suggest that TopBP1 can activate 
ATR and enable Chk1 or p53 phosphorylation in the absence of damaged or primed DNA 
templates (37-39, 41).   
 Claspin is a major mediator of Chk1 phosphorylation and was identified in Xenopus 
egg extracts through a replication stress induced interaction with Chk1 (42). Depletion and 
add back experiments in Xenopus egg extracts showed that Claspin to be required for 
responding to the DNA polymerase α inhibitor aphidicolin or other structures that mimic 
damaged DNA, such as dAdT70 (42-44). Later studies showed that human Claspin is also 
required for Chk1 phosphorylation in cell-free extracts and in vivo where siRNA knockdown 
of Claspin caused premature chromatin condensation, an event that results in genomic 
instability and is a hallmark of intra-S and G2/M phase checkpoint defects (45, 46). Studies 
in Xenopus egg extracts and human cells suggested that Claspin interacts with Chk1 through 
a motif in its C-terminus, conserved throughout metazoans, called the Chk1-binding domain 
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(CBD) (43). Phosphorylation of the CBD after the induction of the ATR-dependent 
checkpoint with UV or other DNA damage mimicking agents such as dAdT70 was also 
important for this response (43). I have used a minimal in vitro checkpoint system to study 
Claspin’s role in the ATR-Chk1 pathway and these findings are described in detail in 
Chapter 2 (41). Point mutations inhibiting phosphorylation of this region were shown to be 
detrimental to Claspin's checkpoint activity in vivo in human cells and in vitro in human 
extracts and Xenopus egg extracts (41, 43, 45 and 46). Studies showed that Claspin is 
specifically expressed in S phase under the control of E2F1 (E2 transcription factor 1), a 
general transcription factor associated with replication genes transcription control (47). 
Claspin protein levels gradually decreases through the end of the G2/M phase which suggests 
that Claspin's role might be specific for replication and control of DNA replication (48). 
Additional research done in Xenopus egg extracts suggested that Claspin interacts with 
replication fork proteins and is loaded at the replication fork right after after Cdc45 and upon 
replicon initiation (49). Interaction of Claspin with several replication fork proteins suggests 
that Claspin may play additional roles unrelated to its role in mediating Chk1 
phosphorylation. Thus, I have studied Claspin interactions with replication fork proteins in 
Chapter 3. It was also suggested that the N-terminus of Claspin is sufficient for recruitment 
to the replication fork through a replication fork-interacting domain (RFID) (49). MRC1, the 
yeast homolog to Claspin, was also shown to play important roles in the regulation of Rad53 
phosphorylation and checkpoint control (36, 50). The rate of DNA replication was altered in 
yeast cells lacking MRC1 compared to wild-type cells; these cells also showed reduced 
viability in response to replication stress induced by hydroxyurea (HU), a chemical agent that 
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depletes nucleotide pools by inhibition of ribonucleotide reductase (51). Mrc1 recruitment to 
the replication fork requires Swi1/Swi3 in yeast and later studies confirmed this interaction in 
Xenopus egg extracts (31, 33). This interaction was studied further in Chapter 3 (27). 
Gel retardation assays and electron microscopy studies of human Claspin showed that 
it directly binds to replication fork DNA (52). In the same study, Claspin was shown to bind 
preferentially to branched DNA structures (52). Later studies done with the fission yeast 
homolog of Claspin, Mrc1, showed similar activities for Mrc1 and that two point mutations 
in the N terminus prevented binding of Mrc1 to DNA (53). Yeast strains expressing a DNA 
binding mutant of Mrc1 were unable to respond to DNA damage induced with HU, which 
suggests that DNA binding might be relevant to Mrc1 and Claspin activity (53). Thus, I have 
studied Claspin-DNA interactions and mapped the minimal replication fork DNA structure 
interaction domain in Chapter 3 (27).  Other studies in yeast and Xenopus have suggested 
that Claspin interacts with the DNA replication machinery (49, 54 and 55). Deletion of the 
replication fork-interacting domain in Xenopus prevents the recruitment of Claspin to 
chromatin and its interaction with other members of the replication machinery (49). Studies 
also showed that Claspin interacts with the leading strand DNA polymerase (pol ε) in yeast 
and Xenopus (49, 54). Both the N- and C-termini of Mrc1 were shown to interact with pol ε 
and the loss of the Mrc1–pol ε interaction causes sensitivity to replication stress and reduced 
survival (54). I have studied this interaction further in Chapter 3 (27). 
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 Transducers 
 Transducer or signal transducer proteins in the checkpoint pathway can be identified 
as proteins which relay the signaling cascade started by sensor proteins to effector proteins 
by activating and stabilizing effector proteins (3). The two major transducer kinases in this 
pathway are Chk1 (Checkpoint kinase 1) and Chk2 (Checkpoint kinase 2) (3). Both proteins 
are phosphorylated upon DNA damage or replication stress by sensor kinases: Chk1 on S317 
and S345 by ATR and Chk2 on T68 by ATM (2-4). Chk2 contains a FHA domain but Chk1 
does not (3).  The FHA domain is reported to bind to phospho-BRCT domains found in many 
other DNA damage checkpoint proteins such as the mediator protein BRCA1 to enable 
recruitment of proteins to the site of DNA damage site for phosphorylation by sensor kinases 
(56). It is currently unknown how Chk1 is recruited to DNA damage sites and stalled 
replication forks, however several mechanisms have been proposed (30, 57). Chk1 was found 
to bind to histones and the non-chromatin fraction of Chk1 was shown to be inactive (57). 
One other mechanism for Chk1 recruitment was suggested to be through Claspin, where 
Claspin may bring Chk1 to sites of damage through Claspin-DNA and Claspin-replication 
fork protein interactions; however, studies were not able to detect a Chk1 or Claspin foci 
using florescence microscopy (30, 40). Studies in Xenopus Chk1 show that Chk1 activity 
towards Cdc25C increases upon Chk1 phosphorylation by ATR (42). Chk1 and Chk2 share 
similar targets, although they are activated by different PIKK members. Chk1 and Chk2 auto 
phosphorylate themselves and other important targets including the Cdc25 family of protein 
phosphatases, p53 and Rad51, which are downstream effectors of the DNA damage 
checkpoint pathway (3). Chk1 phosphorylates Rad51 and activates it to enable 
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recombinatorial repair (3). Chk1 and Chk2 phosphorylate p53 on Ser15 and induce its 
acetylation and stabilization (3, 58). Cdc25A, B and C are also targets of these transducers. 
Although Chk2 phosphorylates these targets, it was shown not to be significant for 
degradation of Cdc25C (3). Activated Chk1 phosphorylates and enables degradation of 
Cdc25C, thus controlling cell cycle progression (3, 5). Due to their important targets, 
transducer kinases are promising drug targets for cancer therapy (5). To understand the 
mechanism of Chk1 phosphorylation by ATR, we have used a minimal in vitro checkpoint 
system with purified proteins in Chapter 2 (Figure 1.4). 
Effectors 
 Effector proteins are direct controllers of cell cycle progression. In the DNA damage 
checkpoint cascade, p53 and the Cdc25 phosphatase family directly control cell cycle 
transitions. Phosphorylated and acetylated stable p53 can act as a transcription factor to 
activate expression of repair genes and the CDK inhibitor p21, which in turn stops cell cycle 
progression through the pRb pathway (3). Cdc25C phosphorylated by Chk1 is degraded and 
inhibited thus unable to dephosphorylate CDKs, resulting in cell cycle arrest until DNA 
damage is repaired. Once Cdc25C is stabilized after repair it can dephosphorylate target 
CDKs and allow progression to M phase (3, 5). The replicative helicase co-factor Cdc45 was 
recently suggested to be a checkpoint effector by controlling late replication origin firing 
(59). Inhibition of Cdc45 and Cdc25C activities are called “immediate” and p53 dependent 
transcriptional response is “sustained” response to the DNA damage checkpoint (3). 
Inhibition of Chk1 pharmacologically in DNA damage induced human cells caused loss of 
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Cdc45-MCM interaction (59). Cdc45 is the replicative helicase co-factor and required for 
initiation of DNA replication and is highly conserved through eukaryotes (7). Together with 
MCM and GINS (Go-Ichi-Ni-San), Cdc45 forms the CMG complex and where Cdc45 and 
GINS were shown to control MCM activity and DNA replication (60). Cdc45 was shown to 
co-immunoprecipitate with Claspin in chromatin fractions in Xenopus egg extracts (25). It 
was also reported that depletion of Xcdc45 prevents Xclaspin recruitment to the replication 
fork (33). Due to the importance of Cdc45 in DNA replication and checkpoint signaling, we 
have studied Claspin-Cdc45 interactions in Chapter 3 (27). 
G2/M checkpoint 
The G2/M checkpoint ensures the absence of any DNA damage before allowing cells 
to enter mitosis, where DNA damage may cause breaking of chromosomes during sister 
chromatid separation and cause genome rearrangements. Similar checkpoint pathway 
activation of ATR-Chk1-Cdc25A/Wee1, in response to UV/base damage and ATM-Chk2-
Cdc25A/Wee1, in response to double strand break, can be initiated in response to DNA 
damage in this system (3, 4). When phosphorylated by Chk1, antimitotic kinase Wee1 is 
activated and phosphorylates and inactivates the mitosis promoting factor (MPF) subunit 
Cdc2, therefore preventing cell cycle progression and anaphase entry (3). 
SUMMARY 
Claspin is a central protein and a mediator of Chk1 phosphorylation and activation in 
the DNA damage checkpoint. Studies show that Claspin is the major mediator of the ATR-
Chk1 pathway and is specific for Chk1, but not other ATR targets. Thus, we have developed 
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a minimal in vitro checkpoint system with purified proteins to study the activity of Claspin. 
We also mapped the minimal activation domain in Claspin. I discuss these findings in 
Chapter 2 (41). Recent studies also showed that Claspin plays important roles in DNA 
replication where recruitment of Claspin to replication fork and to the stalled replication fork 
is also important for facilitating Chk1 phosphorylation. Thus, I have identified direct 
Claspin-interacting partners at the replication fork in vivo and in vitro with purified proteins; 
these findings are discussed in Chapter 3 (27). 
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FIGURE LEGENDS 
Figure 1.1 
Cellular responses to DNA damage and replication stress. 
Cells activate a variety of responses upon DNA damage. DNA damage may occur upon 
exposure to radiation, high energy carrying photons that are found in UV light and reactive 
chemicals and other reactive oxygen species. Internal factors may also cause DNA damage 
such as erroneous DNA replication and DNA repair. 
Cellular responses to DNA damage are controlled by the DNA damage checkpoint system. 
These responses can be: Cell cycle arrest by stopping cell cycle progression or late origin 
firing, transcription of DNA repair genes or cell cycle genes, induction of DNA repair by 
checkpoint mechanisms and ultimately committing to programmed cell death or apoptosis to 
eliminate genetically altered cells. 
Figure modified from (3) 
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Figure 1.2 
Schematic representation of the human DNA damage checkpoint pathways 
Various types of DNA damage or replication stress initiates activation of the checkpoint 
response to control cell cycle. Several classes of proteins have been identified and are 
summarized here. Sensor proteins can be regrouped according to their biochemical 
properties. PIKK members are: ATR, ATM and DNA-PKcs. Other damage sensors and 
activators are: RPA, Rad17-RFC, 9-1-1, MRN and Ku. ATR/ ATRIP, RPA, Rad17-RFC and 
9-1-1 primarily respond to bulky DNA adducts and single-stranded DNA formed during 
replication stress whereas ATM, DNA-PK, Ku and MRN respond to DNA double-strand 
breaks. Mediator proteins are also classified according to which kinases they enable 
phosphorylation of transducers. Claspin, TopBP1 and Timeless/Tipin primarily function in 
the ATR-Chk1 pathway, whereas BRCA1, 53BP1, MDC1 function in the ATM and 
DNAPK-Chk2 pathways. Effector proteins exert their effects on cell cycle progression. 
Members of this class are p53, Cdc25 and Cdc45.  Figure modified from (4) 
 
 
 
 
 
 
 19 
 
Figure 1.3 
Representation of a stalled replication fork and activities of Claspin. 
When the replicative polymerase encounters replication blockage such as damaged base or if  
nucleotide pools are depleted, and while the MCM helicase continues to unwind, a long 
stretch of single-stranded DNA may form. This DNA structure is rapidly covered by the 
ssDNA binding protein RPA which recruits the ATR/ATRIP complex. Checkpoint protein 9-
1-1, loaded by Rad17-RFC, enables the recruitment of TopBP1 to activate ATR/ATRIP at 
the damage site. Claspin forms a complex with Chk1 upon phosphorylation by an unknown 
kinase. ATR/ATRIP then phosphorylates p53 with the help of TopBP1 and Chk1 with the 
help of Claspin and TopBP1. In turn, activated Chk1 phosphorylates p53 and Cdc25C. 
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Figure 1.4 
Representation of reconstitution of minimal ATR-Chk1 checkpoint pathway 
Partially purified human sensor kinase ATR/ATRIP is mixed with BPDE-damaged DNA, the 
mediator proteins TopBP1 and Claspin and target transducer kinase Chk1. Chk1 
phosphorylation occurs only in the presence of mediator proteins and damaged DNA. Chk1 
phosphorylation is detected by western blotting and levels of phosphorylation were equalized 
to the amount of Chk1 in each lane. 
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FIGURE 1.1  
 
Cellular responses to DNA damage and replication stress. 
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FIGURE 1.2  
 
Schematic representation of the human DNA damage checkpoint pathways 
 
 
 
 
 
 
 
 
 
 
 
 
 23 
 
FIGURE 1.3 
 
Representation of a stalled replication fork and activities of Claspin. 
 
 
 
 
 
 
 
 
 
 24 
 
FIGURE 1.4 
 
Representation of reconstitution of minimal ATR-Chk1 checkpoint pathway 
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ABSTRACT 
ATR (ATM and Rad3-related) initiates a DNA damage signaling pathway in human 
cells upon DNA damage induced by UV and UV-mimetic agents and in response to 
inhibition of DNA replication. Genetic data with human cells and in vitro data 
with Xenopus egg extracts have led to the conclusion that the kinase activity of ATR toward 
the signal-transducing kinase Chk1 depends on the mediator protein Claspin. Here we have 
reconstituted a Claspin-mediated checkpoint system with purified human proteins. We find 
that the ATR-dependent phosphorylation of Chk1, but not p53, is strongly stimulated by 
Claspin. Similarly, DNA containing bulky base adducts stimulates ATR kinase activity, and 
Claspin acts synergistically with damaged DNA to increase phosphorylation of Chk1 by 
ATR. Mutations in putative phosphorylation sites in the Chk1-binding domain of Claspin 
abolish its ability to mediate ATR phosphorylation of Chk1. We also find that a fragment of 
Claspin containing the Chk1-binding domain together with a domain conserved in the yeast 
Mrc1 orthologs of Claspin is sufficient for its mediator activity. This in vitro system 
recapitulates essential components of the genetically defined ATR-signaling pathway. 
INTRODUCTION 
DNA damage checkpoints delay cell cycle progression in response to DNA damage 
to maintain genomic integrity. In mammalian cells, two major signaling pathways that 
mediate the checkpoint response have been described: the ATM-Chk2 pathway that is 
activated mainly, but not exclusively, by double-strand breaks and the ATR-Chk1 pathway 
that is primarily activated by UV and UV-mimetic chemical agents as well as replication fork 
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stalling due to DNA damage or nucleotide depletion (1). Upon activation, ATR 
phosphorylates Chk1 on Ser317 and Ser345 in a manner dependent on the mediator protein 
Claspin (2–6). Claspin was originally identified as a Chk1-interacting protein in Xenopus 
laevis egg extracts, where it was shown to be indispensable for ATR-dependent 
phosphorylation of Chk1 (7). Subsequent studies identified a 57-amino acid minimal Chk1-
binding domain (CKBD) of Xenopus Claspin (8). Mutations in this domain abrogate Claspin-
Chk1 association as well as the phosphorylation of Chk1 by ATR in both Xenopus and 
human systems (8-12). 
Genetic studies in human cell lines and in vitro studies with HeLa cell-free extracts 
and Xenopus egg extracts have identified many proteins including RPA, the ATR-ATRIP 
heterodimer, the Rad17-RFC·9-1-1 and Timeless-Tipin checkpoint complexes, TopBP1, and 
Claspin as essential components for phosphorylation of Chk1 and activating the DNA 
damage or replication checkpoints (1). It was found that under certain reaction conditions, 
TopBP1 alone was sufficient to promote phosphorylation of Chk1 by ATR (13). Recently, 
using a defined system, we found that under physiologically relevant ionic strength, Chk1 
phosphorylation by ATR was both TopBP1-dependent and DNA-dependent (14, 15). The 
ATR-Chk1 signaling pathway in these in vitro studies was not dependent on the other 
checkpoint proteins known to be required for ATR activation. A fully reconstituted 
checkpoint system that incorporates all of the genetically defined components would greatly 
facilitate mechanistic studies of this important DNA damage response pathway. In the 
current study, we have analyzed the contribution of Claspin to phosphorylation of Chk1 by 
ATR. We find that Claspin strongly stimulates the TopBP1-dependent ATR phosphorylation 
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of Chk1 but not phosphorylation of other ATR substrates such as p53, and this stimulation is 
amplified by damaged DNA. Claspin functions by increasing the affinity of ATR for Chk1, 
and mutations in the CKBD of Claspin abrogate its mediator activity. We have identified a 
fragment of Claspin that contains the CKBD together with a domain conserved in the Mrc1 
yeast orthologs of Claspin that is sufficient to stimulate ATR phosphorylation of Chk1. Our 
minimal checkpoint system provides a useful platform for analyzing the function of the 
Claspin mediator in the ATR-signaling pathway. 
EXPERIMENTAL PROCEDURES 
Antibodies and DNA 
Chk1 phospho-Ser345 and p53 phospho-Ser15 antibodies were purchased from Cell 
Signaling Technology (Danvers, MA). Chk1, p53, and GST antibodies were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA), and FLAG M2 antibodies were from Sigma. A 
2-kb linear DNA fragment modified with Benzo[a]pyrene diol epoxide (BPDE) was prepared 
as described previously (15, 16). Both single-stranded and double-stranded undamaged 
DNAs stimulate the reaction (14–16); however, because the stimulation of ATR kinase was 
much stronger, we carried out all our experiments with BPDE-DNA in this study. 
Purification of Checkpoint Proteins 
Native ATR-ATRIP, GST-TopBP1-His, GST-TopBP1-C fragment, GST-p53, His-
Chk1 kinase dead (Chk1-kd), and FLAG-tagged full-length Claspin and Claspin Δ851 were 
all purified as described previously (14–17). Point mutations were produced in Claspin by 
site-directed mutagenesis according to the QuikChange® instructions (Stratagene). GST-
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tagged fragments of Claspin were generated by subcloning into pGEX-4T1 (GE Healthcare) 
and purification from Escherichia coli with glutathione agarose was explained in Chapter 3. 
Kinase Assays 
The procedure was similar to our previously described system (16). Briefly, kinase 
assay reactions contained 12 mM Hepes, pH 7.9, 1.2 mM MgCl2, 0.4 mM ATP, 0.3 mM 
dithiothreitol, 0.6% polyethylene glycol 6000, 35 mM KCl, 25 ng/μl bovine serum albumin, 
and 1 μM microcystin in a 10-μl final volume. Unless otherwise indicated, 0.25 nM purified 
ATR-ATRIP was incubated for 15 min at 30 °C with 0.5 nM recombinant full-length 
TopBP1 or TopBP1-C fragment, 10 nM Chk1-kd or p53, with the indicated concentrations of 
Claspin or DNA. The reactions were terminated by the addition of SDS-PAGE loading buffer 
and separated by 10% SDS-PAGE. Chk1 or p53 phosphorylation was detected by 
immunoblotting using the indicated phospho-specific antibodies, and the levels of total Chk1 
and p53 proteins were subsequently detected by immunoblotting the same membrane. Levels 
of phosphorylation were quantified using the ImageQuant 5.2 software after scanning the 
immunoblots. The highest level of Chk1 phosphorylation in each experiment was set equal to 
100, and the levels of phosphorylated Chk1 in the other lanes were determined relative to this 
value, except in Figure 2.1, where the phosphorylation in the first (control) lane was set 
equal to 1 to facilitate the comparison between p53 and Chk1. The averages from at least 
three independent experiments were graphed, and the error bars indicate the average 
deviation from the mean (Figures 2.1–2.5).  
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In the experiments with [γ-32P]ATP, 20 μCi of radiolabel was included in the kinase 
reactions, and the final concentrations of ATP and bovine serum albumin were lowered to 0.1 
mM and 10 ng/μl, respectively. After separation on SDS-PAGE, the proteins were silver-
stained, and then the gel was dried and analyzed by phosphorimaging. For quantification 
purposes, a phosphate standard curve was generated by spotting dilutions of the kinase 
mixture. The amount of Pi incorporated into Claspin or Chk1 was divided by the known 
amount of protein included in the reaction mixture to obtain the number of phosphates 
incorporated into each Claspin or Chk1 molecule. The averages from three independent 
experiments were graphed, and the error bars indicate the average deviation from the mean 
(Figure 2.5D). 
RESULTS 
Claspin Specifically Stimulates ATR Kinase Activity Toward Chk1 
It has been reported that ATR phosphorylation of Chk1 on Ser345, but not 
phosphorylation of other ATR substrates, such as p53, is dependent on Claspin in vivo (6). 
Having obtained the requisite proteins in highly purified forms, we set out to test this model 
in a defined system. Because it has been shown that under certain reaction conditions 
TopBP1 is sufficient to activate ATR kinase on the Chk1 substrate we used this platform to 
test the contribution of Claspin to the phosphorylation of either Ser345 of Chk1 or Ser15 of 
p53 by ATR (13, 14),. The results from such an experiment are shown in Figure 2.1A. 
Claspin significantly stimulates the kinase activity of ATR toward Chk1 (lanes 3–6 versus 
lane 1) but not p53 (lanes 9–12 versus lane 7). Similarly, DNA containing bulky adducts 
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stimulates the TopBP1-dependent phosphorylation of both Chk1 (lane 2) and p53 (lane 8) by 
ATR, consistent with our previous reports (14–16). Thus, although damaged DNA stimulates 
ATR kinase activity on either substrate, the stimulatory effect of Claspin is specific for Chk1. 
Analysis of the in vitro Requirements for Claspin-mediated 
Chk1Phosphorylation 
 
We next tested the optimal requirement and specificity for two essential components, 
ATR-ATRIP and TopBP1, in the Claspin-dependent kinase reactions. The results shown in 
Figure 2.1B indicate that the phosphorylation of Chk1 is completely dependent on ATR-
ATRIP (lanes 1 and 7), and increasing the ATR-ATRIP concentration in the kinase reactions 
resulted in a corresponding increase of Chk1 phosphorylation (lanes 2–6). Importantly, there 
was up to 10-fold more phosphorylation of Chk1 when Claspin was included in the reaction 
mixture (lanes 8–12). 
We have previously shown that the ATR kinase activity in our in vitro system is 
dependent on TopBP1 and that a carboxyl-terminal (C) fragment of TopBP1 is sufficient for 
conferring damaged DNA-dependent stimulation of ATR (14, 15). We wished to determine 
whether the Claspin-dependent stimulation of Chk1 phosphorylation by ATR is also 
dependent on TopBP1 and whether the C-fragment is sufficient. In Figure 2.1C, increasing 
amounts of Claspin were added to reactions lacking TopBP1 (lanes 1–4) or containing full-
length (FL) TopBP1 (lanes 5–8) or the C-fragment of TopBP1 (lanes 9–12). Even at the 
highest concentration of Claspin, no Chk1 phosphorylation is detectable in reactions lacking 
TopBP1 (lane 4), indicating that Claspin alone is not sufficient. However, ATR 
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phosphorylates Chk1 in reactions containing either the full length TopBP1 or the C-fragment 
of TopBP1, and under these conditions, the phosphorylation is completely dependent on 
Claspin (compare lanes 5 and 8 with lanes 9 and 12). This experiment, for the first time, 
reconstitutes a TopBP1-dependent and Claspin-dependent in vitro ATR-Chk1 signaling 
system. 
Mechanistic Details of Claspin-dependent Phosphorylation of Chk1 
Next, we wished to analyze the mechanism by which Claspin stimulates the ATR 
kinase in more detail. First, we performed ATR kinase reactions under conditions of 
increasing ionic strength (Figure 2.2A). As we have previously reported, the TopBP1-
mediated ATR kinase activity is highly sensitive to the ionic strength of the reaction (lanes 
1–8) (14). We find that the stimulatory effect of Claspin is also sensitive to the ionic strength 
(lanes 9–16), with the 2-fold difference in the slopes of the lines of TopBP1- and 
TopBP1+Claspin-stimulated kinase activity, indicating that the Claspin-dependent 
stimulation of ATR is twice as sensitive. This sensitivity to ionic strength is likely due to 
salt-sensitive protein-protein interactions of Claspin required to mediate the kinase reaction. 
The results from kinetic experiments indicate that Claspin increases the initial rate of the 
kinase reaction by ∼5-fold (Figure 2.2B). To better understand the mechanistic basis of the 
effect of Claspin in the reaction, we conducted the experiment shown in Figure 2.2C in 
which the rate of Chk1 phosphorylation was measured as a function of Chk1 concentration in 
ATR kinase reactions lacking Claspin (lanes 1–6) or containing Claspin (lanes 7–12). 
Analysis of these data by the Lineweaver-Burk plot enabled us to estimate the Vmax and Km 
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for the kinase reactions with Chk1 substrate and the effects of Claspin on the kinetic 
parameters. We find that there is less than a 2-fold difference in Vmax for reactions 
containing Claspin (∼91 fmol of Pi/min) than for reactions lacking Claspin (∼57 fmol of 
Pi/min). However, the Km is decreased ∼17-fold by Claspin (Km ∼ 7 nM with Claspin; Km 
∼ 120 without Claspin) (18). Although this ATR kinase reaction is relatively complex 
because of the requirement for multiple protein-protein interactions, the large change in the 
Km indicates that the stimulation of Chk1 phosphorylation observed in the presence of 
Claspin is primarily achieved by increasing the affinity of ATR for Chk1. 
Mutations in the CKBD of Claspin Abolish Its Mediator Activity 
In vivo studies have suggested that the phosphorylations of Thr916, Ser945, and 
Ser982 in the CKBD of Claspin are important for Chk1 phosphorylation by ATR during the 
checkpoint response to DNA damage or stalled replication forks (12). We wished to test this 
observation in our in vitro system to ascertain the validity of this system and possibly gain 
insight into the role of Claspin phosphorylation in the checkpoint response. To this end, we 
used wild-type Claspin, Claspin carrying Thr/Ser → Ala mutations at the phosphorylation 
sites (3A), or the Thr/Ser → Asp phosphomimetic replacements (3D) at these sites in our in 
vitro assay. All three proteins were made in the baculovirus/insect cell expression systems. 
When the three proteins were tested in our assay, the wild-type (WT) Claspin stimulated the 
TopBP1-dependent phosphorylation of Chk1 up to ∼10-fold, whereas the mutants had only 
modest or no effect (Figure 2.3). These results further support the notion that our in vitro 
system is a faithful representation of the in vivo ATR-Chk1 signaling pathway. 
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ATR Phosphorylation of Chk1 Is Stimulated by the C Terminus of Claspin and 
Is Further Stimulated by Damaged DNA 
 
We have previously reported that Claspin is a DNA-binding protein and identified 
DNA-binding domains in fragments encompassing the N- and C-terminal halves of the 
protein (17). We examined the effects of these fragments on Chk1 phosphorylation by ATR 
to better define the role of Claspin in mediating ATR kinase activity. As seen in Figure 
2.4A, either full-length (FL) Claspin (lanes 2–6) or a C-terminal fragment of Claspin (Δ851) 
(lanes 8–12), which contains the CKBD, stimulates ATR phosphorylation of Chk1 up to 10-
fold, and the C-terminal fragment appears to be more active than full-length Claspin, under 
these experimental conditions, suggesting that the N-terminal domain of Claspin may serve 
as a regulator of the reaction. Because this fragment has DNA binding activity and we have 
previously shown that DNA stimulates the kinase activity of ATR in the presence of TopBP1 
we wished to test the effect of adding both Claspin and DNA to the kinase reaction (14, 15, 
17). The results are shown in Figure 2.4B. Under these conditions, the addition of either 
damaged DNA (lane 2) or Claspin (lane 3) results in ∼4-fold more phosphorylation of Chk1 
when compared with the control reaction (lane 1). However, the addition of both DNA and 
Claspin to the reaction (lane 4) resulted in ∼20-fold more phosphorylation than the control 
reaction, which suggests synergy of DNA and Claspin in stimulating ATR kinase because the 
stimulation is more than 2-fold higher than the sum of the kinase activity with either DNA 
alone or Claspin alone. 
Identification of a Minimal Functional Domain of Claspin 
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To more precisely define the region of Claspin sufficient to mediate ATR 
phosphorylation of Chk1 in our system, we generated the fragments of Claspin summarized 
in Figure 2.5A. Fragments spanning the N-terminal half (N) and C-terminal half (C) of 
Claspin were purified from E. coli and tested in the ATR kinase assay (Figure 2.5B). The 
addition of the C-terminal half of Claspin resulted in ∼10-fold stimulation of ATR 
phosphorylation of Chk1 (compare lanes 4 and 5 with lane 1), whereas the N-terminal half of 
Claspin did not have a significant effect on ATR kinase activity (lanes 2 and 3). We further 
truncated the C-fragment, and discovered that the middle (M) region (lanes 6 and 7) was as 
active as the C-fragment. However, further deletions from the N or C termini of the M 
fragment (MΔN, lanes 8 and 9, and MΔC, lanes 10 and 11) abolish the stimulatory effect. 
Therefore, we conclude that the 354 amino acids between amino acid 852 and 1206 are 
sufficient for Claspin to mediate Chk1 phosphorylation by ATR. 
To confirm our findings that mutations of the putative phosphorylation sites in the 
CKBD of full-length Claspin abrogate its function (Figure 2.3), we also tested the effect of 
changing amino acids 916, 945, and 982 to alanine (3A) in the Claspin fragments. The results 
are shown in Figure 2.5C. Mutating the putative phosphorylation sites abolishes the ability 
of either Claspin fragment C (compare lanes 4–6 with lanes 2 and 3) or Claspin fragment M 
(compare lanes 9–11 with lanes 7 and 8) to stimulate phosphorylation of Chk1 by ATR, 
consistent with the results obtained with the full-length protein produced in insect cells. 
Because these mutated residues are putative phosphorylation sites, and the bacterially 
produced protein is not phosphorylated, we wished to measure the amount of 
phosphorylation that occurs at these sites during the kinase reaction. We added radiolabeled 
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ATP to the kinase reactions shown in Figure 2.5D and quantified the amount of Pi 
incorporated in Claspin and Chk1. The addition of wild-type Claspin M-fragment to the 
kinase reaction containing Chk1-kd, TopBP1, and ATR-ATRIP (lane 8) resulted in 10- or 4-
fold more Chk1 phosphorylation as determined by Western analysis of Ser345 
phosphorylation or radioactive analysis of total Chk1 phosphorylation, respectively, than in 
the equivalent reactions lacking Claspin (lane 3) or containing Claspin with the 3A mutation 
(lane 13). In the presence of ATR-ATRIP, ∼0.001 Pi was incorporated per Claspin molecule. 
This was mediated by ATR-ATRIP because there was no measurable radioactivity 
incorporated into wild-type (WT) Claspin (lane 9) or 3A mutant (lane 14) in the absence of 
ATR-ATRIP, and about 4-fold more was incorporated when TopBP1 was also added to the 
reaction (lanes 6 and 11). These results indicate that Claspin is phosphorylated by ATR under 
these reaction conditions, however very inefficiently. Importantly, the amount of Claspin 
phosphorylation is not affected when the putative phosphorylation sites are mutated to 
alanine (compare lanes 5–8 with lanes 10–13), indicating that the three Ser/Thr residues 
(which do not match the ATR phosphorylation consensus sequence) involved in Claspin-
mediated Chk1 phosphorylation are not phosphorylated in this system. 
DISCUSSION 
Development of a Human Reconstituted Checkpoint System 
The genetically defined minimal set of components required for activation of the 
ATR-Chk1 pathway of checkpoint signaling in humans includes DNA, RPA, ATR-ATRIP, 
TopBP1, Rad17-RFC·9-1-1, Timeless-Tipin, Claspin, and Chk1. We previously described a 
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minimal human in vitro checkpoint system consisting of damaged DNA, TopBP1, ATR-
ATRIP, and Chk1 (14, 15). In this study, we have further developed the system to 
recapitulate essential components of the genetically defined ATR-signaling pathway by 
incorporating Claspin. We find that the combination of TopBP1 with Claspin is sufficient to 
strongly stimulate the phosphorylation of Chk1 by ATR and that damaged DNA further 
stimulates the phosphorylation (Figure 2.6). 
Several studies in which HeLa cell-free extracts were used to analyze ATR kinase 
activity have been reported (11, 19, 20). Although these studies have been valuable, the 
presence of other kinases in the extracts makes the results open to alternative interpretations 
and limits their usefulness. Therefore, we have focused on developing a defined ATR 
checkpoint system with purified proteins. Partially reconstituted ATR checkpoint systems 
have been described in other species, including Xenopus laevis and Saccharomyces 
cerevisiae (13, 21–27). A bona fide in vitro checkpoint system should depend on all of the 
checkpoint proteins necessary for Chk1 phosphorylation as defined by genetic data. By these 
criteria, our in vitro system falls short of representing the human in vivo checkpoint pathway. 
However, as it is often encountered in biochemical assays, by employing special reaction 
conditions such as high enzyme concentrations or non-physiological bivalent cations such as 
Mn2+ instead of Mg2+, the in vitro reactions circumvent some of the requirements for the 
reaction in vivo. Such systems nevertheless do contribute to the understanding of the 
biochemical function in question and to the ultimate development of in vitro systems that by 
all criteria recapitulate the in vivo reaction. From that perspective, our study may be 
considered a significant advance over the previous work aimed at establishing an in vitro 
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checkpoint system. We are able to stimulate the ATR kinase phosphorylation of Chk1 by 
checkpoint components known to be required: DNA, TopBP1, and Claspin. 
In Vitro Systems with Xenopus Claspin 
Claspin was originally discovered in Xenopus egg extracts and was shown to be 
indispensable for ATR-dependent phosphorylation of Chk1 in response to stalled DNA 
replication forks in cell-free reactions (7, 22). Reconstitution of a Claspin-dependent reaction 
with purified Xenopus components has been attempted but appears to be complicated by the 
requirement for Claspin to be phosphorylated (8, 10, 21, 22). Mutations of two serines 
(Ser864 and Ser895) in Xenopus Claspin, which have been shown to be phosphorylated 
during the checkpoint response, abrogate its ability to interact with Chk1 and to mediate 
Chk1 phosphorylation by ATR in egg extracts (8, 10, 28). These two serines are located in 
highly conserved repeats of about 10 amino acids in the CKBD of Claspin. Human Claspin 
contains three of these conserved repeats, and our results suggest that although mutations of 
the equivalent putative phosphorylated residues (Thr916, Ser945, and Ser982) abrogate the 
mediator function of Claspin (Figures 2.3 and 2.5C), the residues are not phosphorylated in 
our system (Figure 2.5D). Phospho-specific antibodies have been used to demonstrate that 
Thr916 is phosphorylated in human cell lines after DNA damage, and because the 3A 
mutation abolishes the ability of human Claspin to mediate Chk1 phosphorylation, it was 
concluded that phosphorylation of these sites is required for Claspin function (12, 29, 30). 
The results from our reconstituted system raise some doubt about this conclusion and suggest 
that it is the mutations, not the phosphorylation states of the Ser/Thr residues, that disrupt the 
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mediator function of Claspin. In fact, phosphomimetic mutations at these amino acids abolish 
function in our system (Figure 2.3) and in Xenopus egg extracts (8). The identity of the 
kinase that phosphorylates Claspin on these residues is unknown. These sites do not match 
the ATR consensus sequence SQ/TQ, but ATR appears to be required to activate the kinase 
that phosphorylates these residues (8). An initial report implicated Chk1; however, this was 
subsequently disputed (12, 30). We conducted the experiments in this report with kinase-
inactive Chk1 to avoid this complication. However, we did not detect a difference in the 
Claspin-dependent activation of ATR in reactions containing wild-type Chk1 (data not 
shown), suggesting that if there is significant phosphorylation of these sites by Chk1, it does 
not significantly affect Claspin function in our assay. Ultimately, our system will be useful 
for evaluating the functional significance of Claspin phosphorylation after identification of 
the kinase. 
In Vitro System with Yeast Proteins 
Using purified proteins, it was recently reported that the budding yeast Claspin 
ortholog, Mrc1, stimulates phosphorylation of the Chk1 functional ortholog, Rad53, by the 
Mec1 kinase (ATR ortholog) in a manner similar to our findings (26). However, in contrast 
to our system in which Claspin-dependent ATR phosphorylation of Chk1 is dependent on the 
presence of TopBP1 (Figure 2.1C), the yeast Mrc1/Claspin-dependent checkpoint system 
did not require the addition of the yeast TopBP1 homolog, Dpb11 (26). Similarly, the Rad17-
RFC/9-1-1-dependent yeast Mec1/ATR checkpoint system did not depend on the presence of 
Dpb11/TopBP1, although it was later reported that Dpb11/TopBP1 acted synergistically with 
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Rad17-RFC/9-1-1 in that system (24, 25). We further demonstrated that the C terminus of 
TopBP1 is sufficient for Claspin-dependent stimulation of Chk1 phosphorylation by ATR. 
This fragment of TopBP1 is also sufficient to confer the damaged DNA-dependent 
stimulation of ATR, and in fact, damaged DNA acts synergistically with Claspin in our 
system (Figure 2.4B). 
Conclusion 
Our minimal checkpoint system is the closest approximation to the genetically 
defined human ATR-Chk1 signaling pathway in that it incorporates ATR-ATRIP, Chk1, 
TopBP1, DNA, and Claspin for optimal ATR kinase activity on Chk1. As such, we believe 
this system will provide a useful platform for analyzing the contribution of the other 
components known to be required in the ATR-signaling pathway and ultimately defining the 
roles of the individual components by experimental designs addressing specific questions in a 
readily controllable in vitro system. However, with current technology, it is not possible to 
evaluate the spatio-temporal factors that play an important role in the cellular response to the 
complexity of DNA damage in the nucleus and its effect on cell-cycle progression. 
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FIGURE LEGENDS 
FIGURE 2.1 
Claspin specifically stimulates TopBP1-dependent ATR phosphorylation of Chk1 in a defined 
system.  
 
A, Claspin specifically stimulates ATR phosphorylation of Chk1 but not p53. All reactions 
contain 0.25 nM ATR and 0.5 nM TopBP1. Reactions 1–6 contain 10 nM His-Chk1kd, and 
reactions 7–12 contain 10 nM GST-p53. 1 ng of BPDE-modified 2-kb linear DNA was added 
to reactions in lanes 2 and 8. The values in lanes 1 and 7 are normalized to 1. ATR kinase 
activity was determined by immunoblotting for phospho-Chk1 (α-P-Chk1), Chk1, phospho-
p53 (α-P-p53), and p53 as indicated. The graph shows quantitative analysis of the data from 
three independent experiments conducted under identical conditions. DNA stimulates both 
Chk1 and p53 phosphorylation, whereas Claspin stimulates Chk1 but not p53 
phosphorylation. Values that are statistically different (T value <0.03 in the paired t test) than 
the control reactions (lanes 1 or 7) are indicated with an asterisk. The error bars indicate the 
average deviation from the mean. B, Claspin-mediated phosphorylation of Chk1 is dependent 
on ATR. 0, 0.125, 0.25, 0.5, 1, and 2 nM purified ATR-ATRIP was added to reactions 
lacking Claspin (lanes 1–6) or containing 16 nM Claspin (lanes 7–12) in addition to 0.5 nM 
TopBP1 and 10 nM Chk1kd. The results from three experiments were quantified and plotted. 
0.25 nM ATR-ATRIP was chosen for the later kinase reactions. C, ATR activation by 
Claspin is dependent on TopBP1, and the C-terminal fragment of TopBP1 is sufficient. 
Kinase reactions containing 0, 2, 6, or 18 nM Claspin were performed without TopBP1  
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(lanes 1–4), with 1 nM full-length TopBP1 (FL) (lanes 5–8), or with 1 nM of the TopBP1-C 
fragment (C) (lanes 9–12) 
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FIGURE 2.2 
Claspin mediates the phosphorylation of Chk1 by ATR through a salt-sensitive mechanism that 
increases the affinity of ATR for Chk1.  
 
A, Claspin stimulation of ATR phosphorylation of Chk1 is sensitive to ionic strength. Kinase 
assays were carried out with ATR-ATRIP (0.25 nM), Chk1 (10 nM), and TopBP1-C (0.5 
nM) under different ionic strength conditions (35–105 mM KCl) in the absence or presence 
of 16 nM Claspin. The error bars indicate the average deviation from the mean. α-P-Chk1, 
phospho-Chk1; α-P-Chk1-p53, phospho-p53. B, Kinetics of Claspin stimulation of 
phosphorylation of Chk1 by ATR. Kinase assays were performed as described in the legend 
for Figure 2.1 with 10 nM His-Chk1 and incubated for the indicated amount of time without 
Claspin or with 16 nM Claspin. C, Claspin affects the affinity of ATR for Chk1. Kinase 
assays were performed as described in B, except that the Chk1 concentration varied from 0 to 
50 nM. The results from three experiments were quantified and plotted as before (top graph) 
or with the Lineweaver-Burk format of 1/v versus 1/[S] (bottom graph), which allows for 
calculating the Km = −1/x-intercept and the Vmax = 1/y-intercept. The equation for the lines 
fitting the data for reactions lacking Claspin is y = 2.1049x + 0.0175, and for reactions 
containing Claspin, it is y = 0.0784x + 0.011. The units for Vmax have been determined by 
standardizing the signal from Western blotting to the amount of Pi incorporated in 
experiments containing radioactive [γ-32P]ATP. v, velocity.  
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FIGURE 2.3 
Claspin-mediated ATR activation is dependent on the putative phosphorylation sites in the 
Chk1-binding domain of Claspin.  
 
Kinase assays were carried out with ATR-ATRIP, HisChk1-kd, and TopBP1-C fragment as 
described in the legend for Figure 2.2 except with 35 mM KCl and with 0, 1.5, 3, 6, or 12 nM 
Claspin wild type (WT) or Thr916, Ser945, and Ser982 mutated to alanine (3A) or aspartic 
acid (3D). The graph shows quantitative analysis of the data from five independent 
experiments conducted under identical conditions. The error bars indicate the average 
deviation from the mean. α-P-Chk1, phospho-Chk1. 
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FIGURE 2.4 
The C terminus of Claspin is sufficient to stimulate Chk1 phosphorylation by ATR and acts 
synergistically with damaged DNA.  
 
A, The C terminus of Claspin is sufficient for stimulation of ATR phosphorylation of Chk1. 
Kinase assays were carried out with ATR-ATRIP, HisChk1-kd, and TopBP1 as described in 
the legend for Fig. 1 except with 0, 1, 2, 4, 8, or 16 nM full-length (FL) Claspin or Claspin 
Δ851 fragment. The error bars indicate the average deviation from the mean. α-P-Chk1, 
phospho-Chk1. B, Claspin and DNA synergistically stimulate ATR Kinase. Kinase assays 
were carried out with ATR-ATRIP, HisChk1-kd, and TopBP1-C fragment as described in A 
except with 75 mM KCl and with or without 16 nM Claspin Δ851 and 2 ng of BPDE-
damaged DNA. 
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FIGURE 2.5 
Identification of the minimal functional domain in Claspin.  
A, Schematic of the Claspin fragments and summary of their ability to mediate Chk1 
phosphorylation by ATR. The locations of the putative phosphorylation site mutations at 
Thr916, Ser945, and Ser982 (3A and 3D) in the CKBD are indicated. The Mrc1-like domain 
(MRC1, amino acids 1045–1203) is defined in the Pfam protein families data base as a 
putative domain of average length of 142.3 amino acids that is found to be the most 
conserved region in Mrc1 (31). B, Stimulation of ATR phosphorylation of Chk1 by Claspin 
fragments. Kinase assays were carried out with ATR-ATRIP, HisChk1-kd, and TopBP1 as 
described in the legend for Fig. 1 except with 0, 3, or 30 nM of the indicated Claspin 
fragment. The error bars indicate the average deviation from the mean. α-P-Chk1, phospho-
Chk1. C, Mutations in the Chk1-binding domain of the Claspin fragments abolish their 
ability to stimulate ATR phosphorylation of Chk1. Kinase assays were carried out with ATR-
ATRIP, HisChk1-kd, and TopBP1 as described in B except with 0, 3, 30, or 300 nM of the 
indicated Claspin fragment. D, Kinase assays were carried out with ATR-ATRIP, Chk1-kd, 
and TopBP1 as described in the legend for Figure 2.1 except with the addition of [γ-32P]ATP 
to monitor the total phosphorylation in the reaction. 25 nM wild-type (WT) Claspin-M 
fragment or the Claspin-M fragment containing alanine mutations in the putative 
phosphorylation sites (3A) were included into the reactions as indicated. Half of the kinase 
reaction was loaded onto a gel for analysis by immunoblotting for phospho-Chk1 and Chk1, 
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and the other half of the reaction was loaded onto a separate gel for analysis by silver 
staining and phosphorimaging as indicated. BSA, bovine serum albumin 
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FIGURE 2.6 
Model for Claspin-mediated Phosphorylation of Chk1 by ATR.  
ATR-ATRIP may be recruited to DNA by several mechanisms, all of which eventually lead 
to enhanced kinase activity. Thus, TopBP1 recruits ATR-ATRIP to DNA containing bulky 
adducts (indicated by the triangle). Claspin binds to both DNA and Chk1 and increases the 
affinity of ATR for Chk1 through a mechanism that requires the Chk1-binding domain and 
the MRC1-like domain. Note that this is one mechanism by which ATR and its co-activators 
can be recruited to DNA. There are alternative pathways of recruiting ATR such as by RPA, 
mismatch repair proteins, and other factors. The circled P indicates phosphorylation. 
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FIGURES  
 
FIGURE 2.1 
 
 
 
 
 
Claspin specifically stimulates TopBP1-dependent ATR phosphorylation of Chk1 in a defined 
system. 
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FIGURE 2.2  
 
 
 
 
 
 
Claspin mediates the phosphorylation of Chk1 byATR through a salt sensitive mechanism 
that increases the affinity of ATR for Chk1. 
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FIGURE 2.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Claspin-mediated ATR activation is dependent on the putative phosphorylation sites 
 in the Chk1-binding domain of Claspin. 
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FIGURE 2.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The C terminus of Claspin is sufficient to stimulate Chk1 phosphorylation by ATR and acts 
synergistically with damaged DNA. 
 60 
 
FIGURE 2.5 
 
 
 
 
 
 
Identification of the minimal functional domain in Claspin. 
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FIGURE 2.5 
 
 
 
 
Identification of the minimal functional domain in Claspin. 
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FIGURE 2.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model for Claspin-mediated Phosphorylation of Chk1 by ATR. 
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ABSTRACT 
Claspin is a mediator of the ATR-dependent DNA replication checkpoint in human cells and 
also promotes DNA replication fork progression and stability. Though Claspin has been 
shown to bind DNA and co-immunoprecipitate with other replication fork-associated 
proteins, the specific protein-protein and protein-DNA interactions that are important for 
Claspin function are not known. We therefore purified several domains of human Claspin 
and then tested for direct interactions of these fragments with several replication fork-
associated proteins and with DNA. Our data show that the N-terminus of Claspin binds to the 
replicative helicase co-factor Cdc45, the Timeless protein, and a branched, replication fork-
like DNA structure. In contrast, the C-terminus of Claspin associates with DNA polymerase 
epsilon and Rad17-Replication Factor C (RFC). We conclude that multiple protein-DNA and 
protein-protein interactions may be important for Claspin function during DNA replication 
and DNA replication checkpoint signaling. 
INTRODUCTION 
DNA damage and replication checkpoint signaling pathways respond to DNA 
damage and replication stress during S phase by delaying cell cycle progression, stabilizing 
stalled replication forks, and promoting DNA repair (1, 2) This response is conserved 
throughout eukaryotes and is initiated by specific proteins that sense the presence of single-
stranded DNA (ssDNA) and primer-template junctions at stalled replication forks. Through 
an interaction of the ssDNA-binding protein Replication Protein A (RPA) with the ATR-
interacting protein ATRIP, the DNA damage response kinase ATR is recruited to the ssDNA 
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at these sites (3). Similarly, the Rad17-Replication Factor C (RFC) complex recognizes 
primer-template junctions and loads the 9-1-1 (Rad9-Hus1-Rad1) complex (4). An 
interaction of the C-terminal tail of Rad9 with the ATR-activating protein TopBP1 then 
allows ATR to become fully activated to phosphorylate and activate a number of proteins 
involved in DNA damage checkpoints and DNA repair, including the DNA damage signal 
transducing kinase Chk1 (5-7). 
Using Xenopus egg extracts, a Chk1-interacting protein termed Claspin was identified 
and shown to be required for the phosphorylation and activation of Chk1 in response to 
agents that stall DNA polymerases and activate ATR in the extract (8, 9). Subsequent studies 
in human cells found that the human homolog of Xenopus Claspin functions similarly in 
DNA damage and replication checkpoint signaling (10, 11). Unlike many other proteins 
involved in DNA damage signaling responses, Claspin appears to be specifically required for 
the phosphorylation of Chk1 but not other DNA damage response substrates in response to 
genotoxic stress. (12, 13) Consistent with these data using human cells and Xenopus egg 
extracts, in vitro reconstitution assays with purified proteins recently showed that Claspin 
directly mediates Chk1 phosphorylation by ATR (14) 
The human Claspin protein shows a limited degree of sequence similarity with the 
Mrc1 (Mediator of replication checkpoint) proteins in budding and fission yeast. Yeast 
strains lacking Mrc1 fail to show normal DNA replication checkpoint responses to DNA 
damage and replication stress during S phase (15, 16). Independent of its replication 
checkpoint activity, however, several studies have shown that Mrc1 also co-localizes with the 
replication fork apparatus, where it appears to maintain replication fork stability and promote 
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replication fork progression (17-19). For example, under conditions of replication stress in a 
Saccharomyces cerevisiae strain lacking Mrc1, the replicative MCM (minichromosome 
maintenance) helicase co-factor Cdc45 becomes physically uncoupled from the sites of DNA 
synthesis and the leading strand polymerase Pol ε (DNA polymerase epsilon) becomes 
destabilized at stalled replication forks. (18, 20). Though much of this initial work focused on 
exogenous agents that induce replication stress, it has since been discovered that repetitive 
DNA sequence elements and alternative DNA structures are unstable and sensitive to 
breakage during DNA replication in yeast strains lacking Mrc1 (21-24). Observations that 
Mrc1 immunoprecipitates with several DNA replication fork-associated proteins, including 
Cdc45 and Pol ε, led to the suggestion that Mrc1 physically couples the activities of the 
replicative helicases and polymerases during DNA replication to prevent genome 
destabilization (18, 20, 25-27). Studies using Xenopus egg extracts have also isolated protein 
complexes containing Claspin with these and other replication-fork associated factors, thus 
indicating that the role of Mrc1 in DNA replication may be conserved through evolution 
(28). 
Recent studies in human cells have similarly suggested that human Claspin is 
required for normal rates of replication fork progression and to prevent genome 
rearrangements that may arise at stalled replication forks (29-31). How Claspin associates 
with replication forks and regulates replication fork progression is currently unclear. Though 
Claspin and its fission yeast homolog Mrc1 both preferentially bind to replication fork-like 
DNA structures in vitro, Claspin does not stably associate with chromatin in the absence of 
Cdc45 (32-35). Since Cdc45 is required for the replicative MCM helicase to unwind DNA 
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during DNA replication, these results suggest that the association of Claspin with replication 
forks may be dependent on the replication fork structures that are generated by the MCM 
helicase and/or on direct protein-protein interactions with Cdc45 (36-38). Furthermore, the 
Timeless-Tipin complex (budding yeast Tof1-Csm3 and fission yeast Swi1-Swi3) is an 
additional protein factor that associates and moves with replication forks in a Cdc45-
dependent manner (18, 35). The removal of Timeless-Tipin from Xenopus egg extracts and 
its deletion in yeast also prevents the association of Claspin and Mrc1 with replicating 
chromatin (26, 35, 39). Taken together, these results suggest that several protein-protein and 
protein-DNA interactions may be important for Claspin recruitment and function at 
replication forks during DNA replication and in replication checkpoint signaling. 
To identify the specific protein-protein and protein-DNA interactions that may be 
important for Claspin function, we purified human Claspin, several of its functional domains, 
and a number of replication fork-associated proteins that have been shown to co-
immunoprecipitate with Claspin. We then characterized the binding of the Claspin fragments 
to DNA polymerase epsilon, Rad17-RFC, Cdc45, Timeless, and branched, replication fork-
like DNA. Our results show that the Claspin N-terminus binds to Cdc45, Timeless, and 
DNA, and that the C-terminus binds to DNA polymerase epsilon and Rad17-RFC. These 
results suggest that the binding of different regions of Claspin to specific proteins and to 
DNA may be important for its function in DNA replication and replication checkpoint 
signaling. 
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EXPERIMENTAL PROCEDURES 
Protein purification  
Proteins were purified from either bacterial or insect expression systems. Monolayer 
Sf21 insect cells were cultured in Grace’s insect medium with 10% fetal bovine serum 
(FBS).  The DNA polymerase epsilon holoenzyme was expressed in insect cells after 
infection with baculoviruses encoding the p12 (His-tagged), p17, p59, and p261 subunits 
(gift from J. Hurwitz) and then purified with Ni-NTA agarose using following procedure in 
insect cells were infected equal volumes of viruses expressing subunits above. Cells were 
collected after 48 hours of viral infection with centrifugation at 4’000 x g for 10 minutes and 
washed with 1X DPBS (Dulbecco’s phosphate buffered saline) (Sigma). Then, cells were 
lysed in 10 packed cell volumes of Buffer A (15 mM imidazole, 50 mM Tris pH 7.5, 150 
mM NaCl, 0.1% NP-40, 0.1% Tween-20) for one hour rotating at 4°C. Cell debris and 
insoluble material were removed with ultracentrifugation at 14’000 x g. The supernatant was 
added 10 µl of pre-equilibrated Ni-NTA resin per 1x10e6 insect cells. Then, the resin was 
incubated at 4°C rotating for 4 hours. The resin was separated using centrifugation at 
4’000xg. Resin was then washed three times using Buffer A and once with 1X TBS (50 mM 
Tris pH 7.5, 150 mM NaCl) respectively, prior to elution. Protein was eluted using 250 mM 
imidazole, 50 mM Tris pH 7.5, 150 mM NaCl and stored in the same buffer at -20°C.  
The Rad17-RFC complex was purified from insect cells infected with baculoviruses 
encoding the Rad17 (Flag-tagged), p37 (His-tagged), p40, p36, and p38 subunits using anti-
Flag agarose (Sigma) (4, 45). Flag-Timeless and Flag-Claspin constructs were also expressed 
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in baculovirus-infected insect cells and purified with anti-Flag agarose using similar buffers 
to DNA polymerase epsilon purification. Insect cells were collected after 48 hours of viral 
infection with centrifugation at 4’000 x g for 10 minutes and washed with 1X DPBS 
(Dulbecco’s phosphate buffered saline) (Sigma). The cells were lysed in Buffer B (50 mM 
Tris pH 7.5, 150 mM NaCl, 0.1% NP-40, 1% Tween-20) for one hour on ice. Cell debris and 
insoluble material were removed with ultracentrifugation at 14’000 x g for 30 minutes. The 
supernatant was added 10 µl slurry pre-equilibrated anti-Flag resin per 10
7
 insect cells. The 
resin was incubated at 4°C rotating for 4 hours. The resin was separated using centrifugation 
at 4’000 x g. Resin was then washed three times using Buffer A and once with 1X TBS (50 
mM Tris pH 7.5, 150 mM NaCl) respectively, prior to elution. Proteins were eluted using 
Flag elution buffer (200 ng/ µl Flag peptide (Sigma), 50 mM Tris pH 7.5, 150 mM NaCl). 
The quality of each protein was analyzed by SDS-PAGE and Coomassie blue staining and 
stored in the same buffer at -20°C.  
The GST-Claspin fragments shown in Figure 3.2 were cloned into pGEX-4T1 into 
EcoRI and XhoI sites (GE Life Sciences), expressed in DH5α, and purified with Glutathione 
Sepharose 4B (Amersham Biosciences). GST-Cdc25C (Addgene Plasmid 10969) was 
purified in a similar manner (53). The Cdc45 cDNA was cloned into pGEX-4T1, expressed 
in DH5α, and purified with Glutathione Sepharose 4B resin. DH5α were transformed with 
GST-Claspin fragments, GST-Cdc45 and GST-Cdc25C expression vectors and induced with 
0.5 mM of IPTG at O.D. 0.8 and incubated shaking at 24°C for 5 hours then were lysed in 20 
packed cell volume of Buffer B (50 mM Tris pH 7.5, 1 M NaCl, 0.1% NP-40, 1% Tween-
20). Bacteria were sonicated at high setting with two second on/ off cycle and the lysate was 
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incubated on ice for an additional 30 minutes. Bacterial debris and insoluble material were 
removed with ultracentrifugation at 14’000 x g for 30 minutes. Cleared lysates were added 
50 µl slurry per 1 liter of bacteria pre-equilibrated Glutathione Sepharose 4B. The resin was 
incubated at 4°C rotating for 4 hours. The resin was separated using centrifugation at 4’000 x 
g. Then, the resin was then washed three times using Buffer B and once with 1X TBS (50 
mM Tris pH 7.5, 150 mM NaCl) respectively, prior to elution. Protein was eluted using flag 
elution buffer (200 mM Glutathione (Sigma), 50 mM Tris pH 7.5, 150 mM NaCl). The 
quality of each protein was analyzed by SDS-PAGE and Coomassie blue staining and stored 
in the same buffer at -20°C. 
Protein-protein interaction studies 
Target and bait proteins (5 pmol) were mixed in 50 µl reactions containing Tris-
buffered saline (50 mM Tris pH 7.5, 150 mM NaCl) and then incubated at room-temperature 
for 1 h. Reactions were then diluted to 1 ml with Buffer A, supplemented with Glutathione 
Sepharose 4B resin, and then incubated for 2 h at 4˚C. After centrifugation and three washes 
with Buffer A, proteins were eluted with 1X SDS-PAGE sample buffer, fractionated by SDS-
PAGE, and transferred to nitrocellulose. Membranes were stained with Ponceau S and then 
analyzed by immunoblotting with the indicated antibodies. 
Protein-DNA interaction studies 
A branched DNA structure was generated by mixing Oligo1 (5’-Biotin-
GACGCTGCCGAATTCTGGCTTGCTAGGACATCTTTGCCCACGTTGACCCG-3’) and 
Oligo2 (5’-
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GCGATAGTCTCTAGACAGCATGTGGTAGCAAGCCAGAATTCGGCAGCGTC-3’) in 
an annealing buffer (50 mM Tris pH 7.4, 50 mM NaCl). After heating at 95˚C for 5 min and 
slow cooling, the biotinylated, branched DNA structure was immobilized on Dynabeads M-
280 Streptavidin (Invitrogen) according to the manufacturer’s recommendations. Pull-down 
assays examining the association of the Claspin fragments with the immobilized DNA was 
performed as previously described.43 Binding reactions contained the indicated 
concentrations of proteins and 20 nM DNA in a 50 µl reaction buffer (20 mM Tris pH 7.4, 50 
or 100 mM NaCl, 0.02% NP-40, and 8% glycerol). Associated proteins were analyzed by 
SDS-PAGE and immunoblotting. 
Antibodies 
Rat monoclonal anti-Cdc45 antibody was a gift from Cyrus Vaziri.50 Mouse anti-
Rad17 antibody was described previously.54 Anti-RPA34 antibody (NA-18) was purchased 
from Calbiochem. A monoclonal antibody recognizing the catalytic subunit (p261) of DNA 
polymerase epsilon (ab104) was purchased from Abcam. Antibodies against Claspin (H-300; 
sc-48771) and PCNA (PC10; sc-56) were from Santa Cruz Biotechnology. The guinea pig 
anti-Timeless antibody was a gift from Anthony Gotter.42 The Claspin antibody used for 
immunoprecipitation was from Bethyl (A300-266). 
Immunoprecipitation  
HeLa nuclear extracts were prepared as previously described.55 Nuclear extracts (200 
µg; 100 µl) were mixed with 20 µg of control rabbit IgG  or anti-Claspin antibody (Bethyl 
A300-266) prebound to rProtein A/G+ agarose (Santa Cruz) for 4 h. Reactions were then 
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diluted to 1 ml with Buffer A and incubated for an additional 1 h at 4˚C. The resin was 
washed with Buffer A three times and the proteins were eluted with 1X SDS-PAGE loading 
buffer for analysis by SDS-PAGE and immunoblotting. Immunoprecipitation of Flag-Claspin 
with anti-Flag agarose was performed in a similar manner after adding recombinant Flag-
tagged Claspin (500 ng) to HeLa nuclear extract (400 µg). 
RESULTS 
Claspin interacts with several replication fork-associated proteins in nuclear 
extracts.  
 
Co-immunoprecipitation studies of Xenopus Claspin and budding and fission yeast 
Mrc1 have indicated that several replication fork-associated proteins interact with Claspin 
and Mrc1, including DNA polymerase epsilon (Pol ε), Cdc45, Rad17-RFC, and the 
Timeless-Tipin complex (18, 20, 25-28, 39-41). To determine whether any of these 
interactions are conserved in human Claspin, we immunoprecipitated endogenous Claspin 
from HeLa nuclear extract using an antibody raised against an internal segment of human 
Claspin (amino acids 725-775). As shown in Figure 3.1A, we observed the presence of the 
catalytic subunit of Pol ε, the DNA damage/replication checkpoint protein Rad17, and the 
MCM helicase co-factor Cdc45 in the Claspin immunoprecipitates, but not in the control IgG 
immunoprecipitates. We note that at an association of Claspin with the human homologs of 
Pol ε and Cdc45 has not been previously reported, though it was expected based on the 
evolutionary conservation of these proteins. Rad17 was previously shown to co-
immunoprecipitate with human Claspin and thus served as a positive control in this 
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experiment. Furthermore, we did not observe significant amounts of the replicative clamp 
protein PCNA in complex with Claspin, suggesting that the isolated Claspin 
immunocomplexes were specific and unique (41). Though the replication fork-associating 
Timeless-Tipin complex has been shown to co-immunoprecipitate with Claspin, its absence 
in these particular immunocomplexes indicates that the interaction of Claspin with Pol ε, 
Rad17-RFC, and Cdc45 occur independent of Timeless-Tipin (35, 39, 42, 43). We therefore 
conclude that the Claspin-Cdc45/Pol ε/Rad17 complexes are specific and independent of 
other proteins that are also present at replication forks. 
To confirm the interaction of Pol ε and Cdc45 with human Claspin, we added 
recombinant Flag-tagged Claspin purified from baculovirus-infected insect cells to HeLa 
nuclear extract and then retrieved the Flag-Claspin protein complexes with anti-Flag agarose. 
As shown in Figure 3.1B, both Pol ε and Cdc45 were present in the Flag-Claspin 
immunoprecipitate. We did not detect the 34-kDa RPA2 subunit of Replication Protein A 
(RPA) in the immunoprecipitate, however, suggesting that the complexes that Claspin forms 
with Pol ε and Cdc45 are specific. 
Purification of Claspin and Claspin fragments.  
We next wanted to determine which, if any, of the Claspin co-immunoprecipitating 
proteins directly bind to Claspin. We therefore cloned, expressed, and purified full-length 
and several smaller fragments of human Claspin in either E. coli or baculovirus-infected 
insect cells. A schematic of human Claspin and the various fragments that we purified is 
shown in Figure 3.2A. The fragments were designed, in part, on recent analyses of the 
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Xenopus homolog of Claspin and its functional interactions with DNA, chromatin, and other 
proteins (28). In the schematic in Figure 3.2A, we note a region termed the replication fork-
interaction domain (RFID), which was shown to be sufficient for Claspin to associate with 
chromatin containing stalled replication forks. The RFID contains two smaller regions rich in 
basic amino acids, which were purified and are termed basic patch I (BP1; aa 273-492) and 
basic patch II (BPII; aa 492-622).  The C-terminal half of Claspin (aa 679-1332) contains a 
smaller, minimal region (M; 837-1206) recently demonstrated to be sufficient to mediate the 
phosphorylation Chk1 by ATR in a reconstituted kinase assay with purified proteins (14). 
This fragment contains both a smaller region required for binding of Xenopus Claspin to 
Chk1 (Chk1-binding domain; CBD) and a novel Mrc1-like domain (MRC1) identified 
bioinformatically and shown to be required for mediating phosphorylation of Chk1 by ATR 
in vitro (14). As shown in Figure 3.2B, we obtained relatively high quality and quantity of 
the GST-tagged smaller fragments of Claspin (expressed in E. coli) and Flag-tagged forms of 
larger regions of Claspin (expressed in Sf21 cells). These purified Claspin proteins were then 
used in direct protein-protein interaction assays to test for direct binding of Claspin to other 
replication fork-associated proteins. 
Claspin directly interacts with DNA polymerase epsilon, Rad17-RFC, and 
Timeless.  
 
To examine the direct interaction of Claspin with other replication fork-associated 
proteins, we initially chose to purify Pol ε, Rad17-RFC, and Timeless. Pol ε is a DNA 
polymerase involved in leading strand replication and DNA replication checkpoint control 
(44). Both the Xenopus and yeast homologs of Claspin have been reported to co-
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immunoprecipitate with Pol ε (20, 28). The human Pol ε holoenzyme was purified from 
insect cells co-infected with baculoviruses expressing the four subunits of Pol ε (p261, p59, 
p17, and p12) using a hexahistidine tag on the p12 subunit. As shown in Figure 3.3A (left 
panel), we obtained a high yield of Pol ε at a high level of purity. 
The Rad17-RFC complex facilitates the binding of the 9-1-1 checkpoint clamp to 
primer-template junctions at sites of DNA damage and replication stress (1, 4). 
Phosphorylation of Rad17 was recently shown to be important for Claspin recruitment and 
Chk1 activation in response to replication stress (41). Human Rad17-RFC was purified from 
insect cells infected with baculoviruses expressing Flag-Rad17 and the RFC subunits (p36, 
p37, p38, and p40) using anti-Flag agarose (4, 45). We obtained high quality and a high yield 
of the Rad17-RFC complex (Figure 3.3A, middle panel). 
Several reports using budding and fission yeast, Xenopus, and human cells have 
shown that the Timeless protein and its eukaryotic homologs (XlTim1, ScTof1, and SpSwi1) 
co-immunoprecipitate with Claspin and Mrc1 (26, 35, 39, 42, 43, 46). The Timeless protein 
plays numerous roles in the cell, including in DNA replication, DNA damage checkpoints, 
circadian rhythms, and chromosome cohesion (40, 47). The fission yeast homolog of 
Timeless, Swi1, was initially reported to function as a component of a replication fork 
protection complex that stabilizes replication forks that stall at sites of DNA damage or 
replication stress (48, 49). In Xenopus egg extracts depleted of Timeless, Claspin is unable to 
associate with replicating chromatin (35). We therefore purified Timeless from baculovirus-
infected insect cells using anti-Flag agarose (Figure 3.3A, right panel) to examine its 
interactions with Claspin. 
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To test for direct interactions of Pol ε, Rad17-RFC, and Timeless with Claspin, we 
mixed each of the purified proteins (Figure 3.3A) with the panel of GST-tagged Claspin 
fragments shown in Figure 3.2 and then used glutathione resin to isolate the complexes. As 
shown in Figure 3.3B, Pol ε was specifically retrieved with the C-terminal fragment of 
Claspin (679C). Since nearly 20% of the Pol ε bound to this Claspin fragment under these 
conditions, these results demonstrate that Pol ε is a bona fide Claspin-interacting protein and 
that the C-terminal half of Claspin is sufficient for the interaction. 
We then incubated the Rad17-RFC complex with the GST-Claspin fragments to test 
for a direct interaction. As shown in Figure 3.3C, Rad17 bound only to the C-terminal 679C 
fragment of Claspin but not to any of the other fragments. We conclude that like Pol ε, 
Rad17-RFC and Claspin directly interact with one another through the C-terminal half of 
Claspin. 
Using an identical approach, we incubated Flag-tagged Timeless with the GST-
Claspin fragments and retrieved the complexes with glutathione resin. As shown in Figure 
3.3D, a small amount of Timeless reproducibly bound to the BPII fragment (aa 492-622) of 
Claspin but not to any of the other fragments. Importantly, deletion of this segment from the 
Xenopus homolog of Claspin interferes with its ability to stably associate with chromatin 
(28). 
Our data showing that the Claspin C-terminus directly binds to Pol ε and Rad17-RFC 
and that the BPII fragment interacts with Timeless indicates that specific protein-protein 
contacts are made between Claspin and these replication fork-associated proteins. 
Claspin directly interacts with Cdc45.  
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We then examined whether Claspin forms a direct protein-protein interaction with 
Cdc45. The Cdc45 protein is an accessory factor for the replicative MCM helicase and is 
essential for MCM helicase activity in vitro and for unwinding of DNA at replication origins 
(36, 37, 38). Cdc45 is also a target of the ATR- and Chk1-mediated intra-S phase DNA 
damage checkpoint (50). In Xenopus egg extracts depleted of Cdc45, Claspin is unable to 
associate with chromatin (34, 35). We therefore cloned and expressed a GST-tagged form of 
Cdc45 and purified it with glutathione resin (Figure 3.4A). We chose to use GST-tagged 
Cdc25C (Figure 3.4B) as a negative control for these binding experiments. We then 
incubated Flag-tagged forms of Claspin (full-length, 851N, and 851C; Figure 3.2) with the 
GST-Cdc45 and GST-Cdc25C proteins and used glutathione resin to isolate the protein 
complexes. As shown in Figure 3.4C, the full-length Claspin and 851N fragment (aa 1-851) 
specifically associated with Cdc45 but not Cdc25C. The 851C fragment (aa 851-1332) did 
not bind either protein. The Cdc45 interaction was reproducible and significant, indicating 
that Cdc45 is a bona fide Claspin-interacting protein. 
Claspin binds to replication fork-like DNA.  
Though protein-protein interactions likely play an important role in the stable 
association of Claspin with DNA replication forks or sites of DNA damage and replication 
stress, the direct interaction of Claspin with DNA may also be functionally relevant. Indeed, 
Claspin and Mrc1 both show a higher affinity for replication fork-like DNA structures in 
vitro than for either ssDNA or double-stranded DNA (32, 33) However, the precise domains 
in human Claspin that are important for binding to DNA remain unclear. We therefore used 
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an in vitro pull-down assay to examine the binding of Claspin fragments to a branched, 
replication fork-like DNA structure immobilized on streptavidin-coupled magnetic beads. 
We initially tested full-length Claspin and Claspin fragments under low stringency 
conditions, with a binding buffer composed of 50 mM NaCl. As shown in Figure 3.5A, full-
length Claspin (FL) efficiently associated with the immobilized DNA. However, two C-
terminal fragments of Claspin (679C and M) completely failed to bind to DNA. To identify 
the specific Claspin domain(s) that bind the branched DNA, we then tested the N-terminal 
GST-fragments (224N, BPI, and BPII). Though all three fragments associated with the DNA 
(Figure 3.7A), the BPII region showed the strongest binding, since a higher percentage of 
this fragment than the others was retained on the DNA-beads. To further analyze the DNA 
binding domains of Claspin under more stringent conditions, we modified the binding buffer 
conditions with a higher salt concentration (100 mM). As shown in Figure 3.5B, only the 
full-length and BPII fragment of Claspin were retained on the immobilized DNA under these 
conditions. Based on these results, we conclude that the BPII region of Claspin plays an 
important role in the binding of Claspin to branched, replication fork-like DNA structures.  
 
DISCUSSION 
In this report we showed that human Claspin co-immunoprecipitates with Pol ε and 
the replicative helicase co-factor Cdc45 in human cells (Figure 3.1). Similar approaches 
have previously shown that such complexes exist in yeast and in Xenopus egg extracts (18, 
20, 25, 27, 28, 51). However, a major limitation of the co-immunoprecipitation approach is 
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that it does not provide information about the specific protein-protein interactions that are 
important for protein complex formation. These details are necessary to investigate how 
specific protein-protein interactions regulate enzyme activities. This information is 
particularly important for understanding the mechanisms of multi-protein enzymatic 
processes, such as DNA replication and DNA replication checkpoint signaling. 
To gain a better understanding of the potential mechanisms of Claspin function, we 
purified all of the relevant replication fork-associated, Claspin co-immunoprecipitating 
proteins in recombinant form and examined direct binding to Claspin. We further 
characterized the specific regions of Claspin that are involved in these protein-protein 
interactions and for binding to branched, replication fork-like DNA. A summary of these 
findings are provided in Figure 3.6. Our data show that the N-terminus of Claspin, which 
contains a replication fork-interacting domain (RFID) previously shown to be sufficient for 
Claspin association with chromatin in Xenopus egg extracts is also involved in directly 
binding to the replicative MCM helicase co-factor Cdc45 (Figure 3.4) and the replication 
fork protection complex protein Timeless (Figure 3.3) (28). Because Claspin fails to 
associate with replicating chromatin in Xenopus egg extracts lacking either Cdc45 or 
Timeless, these results suggest that the interactions of Cdc45 and Timeless with the Claspin 
N-terminus may be important for stably recruiting Claspin to newly generated replication 
forks (34, 35). Alternatively, Cdc45-dependent MCM helicase activity may generate 
unwound DNA structures that allow Claspin to directly bind to DNA. Consistent with this 
latter hypothesis, both Claspin and Mrc1 preferentially bind branched DNA structures 
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through N-terminal domains (32, 33). Though there are multiple DNA binding elements 
within this region of Claspin, the BPII domain has the greatest affinity for DNA (Figure 3.5). 
In yeast strains lacking Mrc1 and exposed to the nucleotide-depleting agent hydroxyurea, 
Cdc45 becomes physically uncoupled from the sites of DNA replication, suggesting that 
Mrc1 may control the activity of the replicative DNA helicase (18). Thus, the direct 
interaction that we observed between Claspin and Cdc45 (Figure 3.4) may regulate Cdc45-
dependent MCM helicase activity. Clearly additional work is necessary to understand how 
the Cdc45-Claspin, Timeless-Claspin, and DNA-Claspin interactions affect the functions of 
these proteins in DNA replication and DNA replication checkpoint signaling. 
Whereas the N-terminus of Claspin appears to have functions relating to its 
association with DNA replication forks, the C-terminus is primarily thought to be involved in 
ATR-mediated DNA damage and replication checkpoint signaling (14, 28). Importantly, a 
region in the C-terminal part of Claspin was recently shown to be sufficient to directly 
mediate Chk1 phosphorylation by ATR in a defined system in vitro (14). This minimal 
checkpoint domain (Figure 3.6) contains both a Chk1-binding domain (CBD) and a region of 
similarity to yeast Mrc1. 
Interestingly, the C-terminal half of Claspin also mediates its interactions with two 
additional proteins-DNA polymerase epsilon and Rad17-RFC. The Rad17-RFC complex has 
a well-recognized role in loading the alternative DNA damage 9-1-1 clamp onto primer-
template junctions at sites of DNA damage and replication stress in order to facilitate 
activation of ATR (1, 4). Importantly, a previous report suggested that the phosphorylation of 
Rad17 by checkpoint kinases was required for Claspin recruitment and function at sites of 
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DNA replication stress (41). Though our data confirm that Rad17-Claspin complexes exist in 
human cells (Figure 3.1), our data now show that the interaction involves direct contacts 
between the two proteins (Figure 3.3). 
We further found that the same C-terminal region of Claspin (679C) is also involved 
in binding to Pol ε. This is in agreement with a recent publication in fission yeast, where it 
was reported that the C-terminus of Mrc1 was sufficient to co-immunoprecipitate with the C-
terminus of Pol ε (20). It should be noted that this interaction affected yeast growth rate, 
independent of Mrc1 checkpoint functions. It will therefore be important to determine how 
this interaction affects cell growth or DNA replication rate in human cells.  
In conclusion, our results suggest a model where Claspin function in DNA replication and 
DNA damage and replication checkpoints may be influenced by multiple protein-protein and 
protein-DNA interactions. An understanding of the domains important for these interactions 
will therefore facilitate future work aimed at understanding how these various protein-protein 
and DNA –protein interactions influence DNA replication, DNA damage checkpoints, and 
genomic stability. 
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FIGURE LEGENDS 
Figure 3.1  
Claspin co-immunoprecipitates with replication fork-associated proteins cell extracts.  
A, HeLa nuclear extract (200 µg) was immunoprecipitated (IP) with either rabbit IgG or anti-
Claspin antibody. Immunoprecipitates (50%, except for the Claspin immunoblot, which was 
10%) were fractionated by SDS-PAGE and analyzed by immunoblotting (IB) with antibodies 
against the indicated proteins. Input lane represents 1% of the starting nuclear extract used 
for the immunoprecipitation. The SDS gel was also stained with Coomassie blue to visualize 
the immunoprecipitated Claspin. B, HeLa nuclear extract (400 µg) was supplemented (+) or 
not (-) with recombinant full-length Flag-Claspin (500 ng) and then incubated with anti-Flag 
agarose. Immunoprecipitated (Flag IP) proteins were analyzed by SDS-PAGE and 
immunoblotting (IB) with antibodies against the indicated proteins. Input represents 1% of 
the starting nuclear extract used for the immunoprecipitation. The immunoprecipitated Flag-
Claspin was visualized by staining the nitrocellulose membrane with Ponceau S. 
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Figure 3.2 
Schematic and purification of recombinant Claspin fragments.  
A Schematic of Claspin fragments cloned and purified in either E. coli or insect cells. 
Abbreviations for the names are provided to the right of the schematic. The numbers indicate 
the amino acid (aa) positions. Several important functional domains are presented in the 
schematic, including the replication fork-interacting domain (RFID, amino acids 273-622), 
basic patch I (BPI, aa 273-492), basic patch II (BPII, aa 492-622), Chk1-binding domain 
(CBD, aa 899-999), and an Mrc1-like domain (MRC1, aa 1045-1203). The purified Claspin 
proteins and fragments included: full-length (FL), aa 851-1332 (851C), aa 1-851 (851N), aa 
679-1332 (679C), aa 837-1206 (M; minimal checkpoint domain), aa 1-224 (224N), aa 273-
492 (BPI), and aa 492-622 (BPII). B, The indicated recombinant Claspin fragments were 
purified with either a GST epitope from E. coli or as with a Flag-epitope from baculovirus-
infected insect cells. An aliquot of each of the purified proteins was analyzed by SDS-PAGE 
and Coomassie blue staining. The numbers to the left of the Coomassie-stained gel indicates 
the location of the molecular weight markers (kDa). 
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Figure 3.3 
Claspin directly interacts with Pol ε, Rad17-RFC, and Timeless.  
A, Purified Pol ε (left panel), Rad17-RFC (middle panel), and Timeless (right panel) were 
purified as described in the Materials and Methods section and analyzed by SDS-PAGE and 
Coomassie blue staining. Arrows indicate each protein or subunit. The asterisk represents 
impurities in the purified protein. The numbers to the left of the Coomassie-stained gel 
indicates the location of the molecular weight markers (kDa). The indicated GST-Claspin 
fragments shown in Figure 3.2 were mixed either B Pol ε, C Rad17-RFC, or D Timeless, 
retrieved with glutathione resin, and analyzed by SDS-PAGE and immunoblotting with 
antibodies against the indicated proteins. The GST-Claspin fragments were visualized by 
staining the membrane with Ponceau S. Input represents 10% of the protein tested in the 
binding assays. The relative amount of each protein that co-precipitated with each Claspin 
fragment was quantified and normalized relative to the input signal. Error bars represent the 
standard deviation of the mean from two (Timeless) or three independent experiments (Pol ε, 
Rad17-RFC).  
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Figure 3.4  
Claspin directly interacts with Cdc45.  
A GST-Cdc45 and B GST-Cdc25C were purified from E. coli with glutathione resin and 
analyzed by SDS-PAGE and Coomassie blue staining. The arrows indicate the full-length 
purified proteins. The numbers to the left of the Coomassie-stained gel indicates the location 
of the molecular weight markers (kDa). The purified GST-Cdc45 had a number of 
degradation products, as visualized in the Coomassie-stained gel and verified by 
immunoblotting with an anti-Cdc45 antibody. C Flag-tagged Claspin fragments shown in 
Figure 2 were mixed with either GST-Cdc45 or GST-Cdc25C, incubated with glutathione 
resin, and bound proteins analyzed by SDS-PAGE and immunoblotting with anti-Flag 
antibody and Ponceau S-staining of the membrane. D The relative amount of each protein 
that co-precipitated with each GST-tagged protein was quantified and normalized relative to 
the input signal (10% of material used in the binding assay). Error bars represent the standard 
deviation of the mean from three independent experiments.  
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Figure 3.5  
The Claspin N-terminus but not the C-terminus binds to replication fork-like DNA in vitro. 
Each of indicated the GST-Claspin fragments (20, 40, and 100 nM) was incubated with a 
biotinylated, branched DNA substrate (20 nM) immobilized on magnetic beads, as described 
in the Materials and Methods section. Binding reactions were performed with either A 50 
mM NaCl or B 100 mM NaCl in the binding and wash buffer. Proteins bound to the DNA-
beads were analyzed by SDS-PAGE and immunoblotting. Input lanes contain 0.5 pmol of the 
indicated protein. Signals were quantified using the input signal for normalization and then 
graphed. Data represent the mean and standard deviation from three independent 
experiments. 
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Figure 3.6 
Schematic of Claspin functional domains.  
A summary of the functional regions of Claspin are indicated, based on data described in the 
text. BPI and BPII indicate basic patches I and II. RFID, replication fork-interacting domain. 
CKB, Chk1-binding domain. MRC1, Mrc1-like domain. 
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FIGURES 
 
Figure 3.1 
Claspin co-immunoprecipitates with replication fork-associated proteins cell extracts.  
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Figure 3.2 
Schematic and purification of recombinant Claspin fragments.  
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Figure 3.3 
Claspin directly interacts with Pol ε, Rad17-RFC, and Timeless.  
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Figure 3.3 
Claspin directly interacts with Pol ε, Rad17-RFC, and Timeless.  
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Figure 3.4 
Claspin directly interacts with Cdc45.  
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Figure 3.5 
The Claspin N-terminus but not the C-terminus binds to replication fork-like DNA in vitro. 
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Figure 3.6 
Schematic of Claspin functional domains.  
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 DNA damage checkpoints maintain genome stability and accurate transmission of 
genetic material to daughter cells (1, 2). Components of these systems have been shown to be 
important in tumorigenic transformation and cancer progression; thus, DNA damage 
checkpoint pathways are valuable targets of therapeutics (3-5). Since in vivo studies provide 
only a general understanding of the proteins involved in DNA damage checkpoint signaling, 
in vitro studies are needed to achieve a better understanding of the mechanisms of these 
signaling cascades.  
Claspin functions in ATR-Chk1 signaling pathway 
The ATR-Chk1 signaling pathway enables the cell to control a variety of cell cycle 
and DNA repair factors (2- 4). Chk1 and ATR are not the only targets for drug development, 
but the other proteins they regulate are also potential targets for cancer drugs, such as Cdc25 
family of protein phosphatases (5). Pharmacological inhibitors often target the enzymatic 
activities of the proteins. However, this poses a common side effect when the enzyme shares 
active sites of the same or homologous protein families, as is the case for kinase active sites. 
Mediator proteins such as Claspin may provide more specificity than such inhibitors. Our 
research in Chapter 2 suggests that Claspin’s mediator activity is limited to Chk1 
phosphorylation and that p53 phosphorylation by ATR is not mediated by Claspin (6). Chk1, 
in turn, activates an “immediate” response rather than the p53-mediated “sustained” 
response (3, 6). Peptides targeting the Chk1-Claspin interaction were used in vitro in human 
extracts to successfully inhibit Chk1 phosphorylation by ATR (7). This research was enabled 
by the identification of a CBD in Claspin (8). In this dissertation, I purified and characterized 
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multiple functional domains in Claspin with respect to its direct protein-protein interactions 
in vitro and in vivo and its checkpoint activity in a minimal reconstituted ATR-Chk1 
checkpoint system (6, 9). Although many replication fork proteins have been 
immunoprecipitated with Claspin, many of these interactions were identified in yeast or 
Xenopus, and no direct interaction studies with purified proteins were done (10-15). As in the 
example of the CBD identification and use of peptides as inhibitors, my findings will enable 
future research understanding the importance of the Claspin- replication fork protein 
interactions (7).  
Claspin binds to replication fork structures 
Studies showed that Claspin and yeast Mrc1 binds to DNA and preferentially to 
replication fork structures (16, 17). The Mrc1 DNA binding domain was identified and was 
shown to be important for survival upon replication stress (17). The yeast protein has very 
minor amino acid conservation to the human protein (6, 9, 16, 17). In Chapter 3, I identified 
a 130 amino acid region in the RFI domain (BPII) as the minimal replication fork-like DNA 
interaction domain (9). Other N-terminal fragments showed lower DNA binding affinities 
(9). Although this region is not conserved in the primary structure, both BPI and BPII regions 
are composed of highly basic patches of amino acids (9). In fact, point mutations in yeast 
MRC1 that abolish DNA binding are in a basic helix-turn-helix motif (17). This strengthens 
the argument that there is homology and structural conservation between the two proteins. 
These findings add to the importance of the DNA binding property of human Claspin, since 
the DNA binding motifs are structurally conserved. Point mutation studies in the BPII region 
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of Claspin should be done to produce DNA binding mutants to understand the physiological 
importance of Claspin DNA binding activity. In vitro, we were unable to detect any M 
fragment–replication fork DNA structure complexes, though the M fragment was shown to 
be the minimal region required for Claspin’s mediator activity in the ATR-Chk1 checkpoint 
which was studied in Chapter 2 (6, 9). This proves that the DNA binding activity of Claspin 
is not essential in this minimal checkpoint system.  
Claspin checkpoint and replication functions 
It has been suggested that the Claspin N-terminus is required for recruitment to 
replicating chromatin and interactions with replication fork and checkpoint proteins in 
Xenopus egg extracts (12). In the light of these findings and my results, I speculate that 
interactions of Claspin with Cdc45, Timeless and replication fork DNA at the N-terminus 
may enable the recruitment of Claspin to replicating chromatin. The recruitment of Claspin 
may then enable Chk1 recruitment to the vicinity of ATR in vivo. We observed that the CBD 
alone was not sufficient to mediate Chk1 phosphorylation in vitro (6). A conserved 
MRC1LD was also required (6). Studies done in Xenopus suggest that a chimeric protein 
containing the Chk1 activation domain (CKAD) consists of BPIII (found in Xenopus Claspin 
and) CBD of Xenopus Claspin can rescue Chk1 phosphorylation in Claspin depleted 
aphidicolin treated egg extracts (8). MRC1LD consists of basic amino acids and has minimal 
homology to the yeast homolog of Claspin (6). One can speculate that these basic patches 
may serve as charged protein-protein interaction motifs. Chimeric proteins consisting of 
Claspin functional domains in depletion/add back experiments or knockdown/ectopic 
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expression experiments may enable a further understanding of what each domain does and 
the synergistic effects of these domains in vivo or in vitro.  
Regulation of Claspin activity 
Xenopus and human Claspin were shown to be phosphorylated by an ATR-dependent 
kinase in the CBD repeat motifs (7, 18). This phosphorylation was suggested to be required 
for activation of Claspin and interaction of Claspin with Chk1 to enable Chk1 
phosphorylation by ATR (7, 8, 18-20). However, the kinase that phosphorylates these 
residues remains unknown (6). In our minimal reconstituted system, where a partially 
purified ATR and recombinant proteins purified from bacteria or insect origin were used, we 
did not observe a difference in radioactive phosphate incorporation between the mutant M 
fragment which contains Ser to Ala point mutations in the CBD motifs, and the wild-type M 
fragment (6). This may be due to limitations of the assay, where several serine and threonine 
residues are present on these domains; however, we have not observed a substantial amount 
of radioactive phosphate incorporation in these fragments (6). Our results may suggest that 
phosphorylation of Claspin at these residues is not required in our minimal system (6). One 
other possible explanation may be that only a small number of Claspin molecules is 
phosphorylated and becomes activated in our system; Claspin may have a high turnover rate, 
where one molecule of Claspin may be reused to recruit multiple molecules of Chk1. In fact 
studies done with fluorescent microscopy were not able to detect stable Claspin-Chk1 foci at 
damage sites (21). Another possible explanation may be that the partially purified ATR does 
not contain this Claspin kinase and thus Claspin is not efficiently phosphorylated. 
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Alternatively, radioactive phosphate incorporation of the M fragment may be due to 
phosphorylation by ATR on Ser852, which was reported elsewhere, and the non-
phosphorylated CBD of the Claspin in M fragment is still active to a certain extent (6, 22). 
Identification of the Claspin kinase that phosphorylates Claspin on CBD may enable an 
understanding of how Claspin is post-translationally regulated. 
Claspin functions in DNA replication 
Studies suggest that Claspin may be important in regions of the genome that are 
difficult to replicate , such as fragile sites (23). However, no chromatin immunoprecipitation 
studies have been done with human Claspin; nor is the presence of a replication fork 
protection complex (RFPC) widely recognized. We have observed interactions of Claspin 
with the following replication fork proteins: Rad17-RFC, Timeless, Cdc45 and pol ε (9). 
Direct interaction with Tipin was studied elsewhere (24). Interaction of Claspin with pol ε 
was studied in yeast, and this interaction was shown to be required for survival upon 
replication stress (13). Interactions with Timeless/Tipin studies suggest that Claspin might be 
recruited to replication forks via this complex (11). Together, Timeless/Tipin and Claspin 
may form a RFPC which may be important to keep the replication fork from dissociating 
abruptly, resulting in re-replication or un-replicated regions and amplification of the stalled 
region problems; however, further studies are needed to challenge the presence and 
importance of this complex (11, 25, 26). Nonetheless, I have reported here in Chapter 3 that 
specific regions of Claspin interact directly with RFPC components (9). I have also shown 
here that Claspin interacts with pol ε but not with PCNA or RPA (9). This might be due to 
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the stringency of the binding conditions, where Claspin may interact with pol ε off DNA and 
not with PCNA or RPA; though PCNA, RPA and pol ε are well established members of the 
replication fork, I have yet to detect such a complex. Since Claspin interacts both with Cdc45 
and pol ε, through different domains, I can speculate that Claspin may link the leading strand 
polymerase with the unwinding helicase, thus enabling cross talk between these proteins. 
Chromatin immunoprecipitation and chimeric Claspin domains that can minimally associate 
with both pol ε and Cdc45 in vitro may prove the presence of such complexes. 
Claspin in human diseases 
Fragile sites and repeat regions have been reported in repeat expansion diseases and 
are poorly understood (23, 25-27). A very recent study suggests that Claspin expression is 
consistent with neurogenic stability in Huntington patients (28). Strikingly, Claspin was the 
only gene whose mRNA levels were affected in the DNA damage checkpoint system 
proteins in this research (28). This suggests that Claspin is an important target of cell cycle 
control. Recent studies also suggest that Cdc7, a direct controller of cell cycle progression 
through regulation of replication, also affects Claspin protein stability and thus exerts its 
function in ATR-Chk1 pathway (29). Viral sources also utilize degradation of Claspin as a 
tool to hijack replication machinery and inhibit DNA replication checkpoint signaling. 
Human papilloma virus (HPV) cause cervical cancers, the HPV16-E7 protein was shown to 
accelerate Claspin degradation and thus, inhibit cellular stress responses and hijack the 
replication machinery (30). Interestingly, Claspin was not strongly implied as a tumor 
suppressor or oncogene and no mutations have been reported to imply a role for it in 
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tumorigenesis, this might be due to its essential roles in replication. One study suggested that 
since its expression increases cellular proliferation rate, it might be classified as a proto-
oncogene (31). However, due to its regulatory activities, Claspin may also play tumor 
suppressor role as implied in HPV induced cervical carcinoma (30, 32). 
In conclusion, I have studied Claspin, with respect to its biochemical properties and 
functional domains, its interactions with replication fork and checkpoint proteins and 
identified its minimal checkpoint domain. It is now well established in the field that Claspin 
is a replication fork protein and plays important roles in checkpoint signaling.  My results 
will enable future research on understanding the mechanisms of Claspin function and a better 
understanding of the interface between DNA replication and checkpoint signaling. 
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